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ABSTRACT
3-Nitrofluoranthene (3-NFA) and 2-nitrofluoranthene
(2-NFA) are environmental pollutants produced during
combustion processes, proven to be mutagenic in bacterial
assays and potentially carcinogenic in mammalian species.
3-NFA was incubated with Salmonella typhimurium strain
TA98 and its variants TA98 ND and TA98/1,8-DNP6, deficient
in nitroreductase and transacetylase enzymes respectively.
All three strains produced equal amounts of the reductive
metabolite 3-aminofluoranthene (3-AFA) over six hours of
incubation.  The nitroreductase deficient strain TA98 ND
produced the metabolite at a slower initial rate of
conversion than the nitroreductase proficient TA98 and
TA98/1,8-DNP6.  2-NFA incubated with TA98 and TA98 ND
produced two identifiable metabolites 2-aminofluoranthene
(2-AFA), and N-acetyl-2-aminofluoranthene (2-NAAFA) within
24 hours of incubation.  The production of metabolites by
TA98 ND was significantly slower than that of TA98.
TA98/1,8-DNP5 produced only 2-AFA at slower rates than TA98.
The metabolism of 2-NFA by the Salmonella strains
progressed at slower rates than that of 3-NFA.  This
reflects the difference observed in the mutagenicity of
these compounds as measured by the Ames assay (3-NFA highly
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I.       INTRODUCTION
3-NFA and 2-NFA are isomers of nitrated polycylic
aromatic hydrocarbons commonly produced by combustion
processes (Nielsen et al., 1984; Zielinska et al., 1986).
Because of widespread environmental exposure and
experimental evidence for mutagenicity and/or
carcinogenicity associated with these compounds, 3-NFA and
2-NFA have the potential to affect human health (DiPaolo et
al., 1983; Griebokk et al., 1985; Ball et al., 1986b.; Ball
unpublished data).
A large part of the mutagenic response to nitroarenes
seen in the Ames assay has been attributed to bacterial
metabolism by the nitroreductive enzymes present in the cell
system (Rosenkranz et al., 1982; Rosenkranz and Mermelstein,
1983).  During the conversion of 3-NFA and 2-NFA to 3-AFA
and 2-AFA respectively, a reactive intermediate, N-hydroxy-
aminofluoranthene is produced.  This reactive intermediate
can form highly elctrophilic arylnitrenium ions which can
either directly interact with cellular DNA or rearrange to a
carbonium ion, also a potentially reactive electrophile
(Karpinsky et al., 1984; Howard et al., 1983b.; Patton et
al., 1986).  This interaction with DNA causes the formation
of adducts (Dietrich, 1987) which can interfere with normal
cellular function.
The Salmonella typhimurium strains chosen for this study
are commonly used in Ames assays to screen for a variety of
possible mutagenic compounds.  TA98 is a nitroreductase
competent strain of Salmonella expressing both the
"classical" and "non-classical" nitroreductive enzyme
systems responsible for the metabolism of most nitro-PAHs
(Rosenkranz et al., 1980; McCoy et al., 1981).  TA98 ND, a
variant of TA98, is deficient in the "classical"
nitroreductases (Rosenkranz et al., 1982; Orr et al., 1985).
TA98/1,8-DNP6, also a variant of TA98, is "classical" and
"non-classical" nitroreductase competent but lacks acetyl
CoA dependent transferase activity which blocks
esterification of arylhydroxylamines to hydroxamic esters
(McCoy et al., 1983; Orr et al., 1985).
The purpose of this study was to analyze the reductive
metabolites of 2-NFA and 3-NFA formed by three variant
strains of Salmonella typhimurium (TA98, TA98 ND, and
TA98/1,8-DNP6).  A possible metabolic basis for differences
in mutagenic potency among the variants of Salmonella
typhimurium and isomers of nitrofluoranthene would be
investigated.  Enough metabolic products had to be collected
to allow for characterization of the structure of the
metabolite by analytical chemistry techniques.
II.       LITERATURE   REVIEW
A.  3-Nitrofluoranthene and 2-Nitrofluoranthene in the
Environment
Nitrated polycyclic aromatic hydrocarbons (nitro-PAHs)
are common combustion products widely dispersed throughout
the environment (Nishioka et al., 1982; Gibson, 1982:
Schuetzle et al., 1982; Wise et al., 1985; Brorstrom-Lunden
and Lindskog, 1985).  2-Nitrofluoranthene (2-NFA), a member
of the nitro-PAH family, is detected in extracts of ambient
air particulate matter from urban and rural areas (Nielsen
et al., 1984; Pitts et al., 1985).  3-Nitrofluoranthene
(3-NFA), another family member, has been detected on diesel
emission particulate matter in addition to other particulate
matter from other sources of combustion (Gibson et al.,
1982; Later et al., 1982; Nishioka et al., 1982; Shuetzle et
al., 1982).  1-Nitropyrene (1-NP), a well characterized
isomer of 2-NFA and 3-NFA (Figure 1), has also been detected
in emissions from combustion sources.
Most nitro-PAHs are considered to be biologically inert,
requiring metabolism to a reactive species before exerting
biological activity.  Many nitro-PAHs have proven to be
highly mutagenic (Rosekranz et al., 1980; Mermelstein et
al., 1981; DiPaolo et al., 1983; King et al., 1984; Wong,
1986; Berry, 1985; Vance and Levin, 1984) and carcinogenic
(Oghaki et al., 1982; Lewtas, 1983; Hirose et al., 1984;
Wislocki et al., 1986).
Because of widespread environmental exposure as well as
experimental evidence for mutagenicity and/or
carcinogenicity associated with these compounds, 2-NrA and
3-NFA have the potential to affect human health.  In vivo
studies have shown that even though inhaled diesel or other
combustion particulates are rapidly cleared from the lungs,
a significant fraction of the particulate matter remains in
the lung allowing for release and metabolism of organic
components from the particulates under normal physiological
conditions (Brooks et al., 1980; King et al, 1981; King et
al., 1983a.)-  Furthermore, the particulate matter that is
cleared from the lung by the mucociliary elevator often
descends into the gastro-intestinal tract where the
associated organic matter is susceptible to further cellular
and bacterial metabolism and absorption into the body.
B.  Formation of Nitro-PAHs
The accepted theory of nitro-PAH formation revolves
around the nitration of PAHs present in combustion gases and
on particulate matter either during combustion or while
circulating in ambient air (Nielsen et al., 1984; Zielinska
et al., 1986).  Many parameters influence the formation of
nitro-PAHs including temperature, sunlight, reactant
concentration, chemical structure of the parent PAH, ozone
concentration, and surface characteristics of the material
on which the PAH is adsorbed (Nielsen, 1983; Nielsen, 1984;
Kamens et al., 1985; Zielinska et al., 1986).
Figure 2 outlines how nitro-fluoranthenes are thought to
be produced during combustion and while circulating in
ambient air (Kamens et al., 1985; Zielinska et al., 1986).
Nitrogen oxide species (NO^, dinitrogen pentoxide [N2O5],
nitric acid [HNO3]) produced during and after combustion can
readily react with fluoranthene molecules, also produced
during combustion, via free radical or ionic mechanisms.
The most reactive site for electrophilic substitution on the
fluoranthene molecule is believed to be the C3 position, the
site of highest electron density (Zielinska et al., 1986).
3-NFA has been shown to be the dominant isomer formed in the
liquid and solid phases arising from direct nitration of the
fluoranthene molecule by NO2/N2O4 or NOj^ (Schuetzle et al.,
1982; Zielinska et al., 1986).  2-NFA is believed to be the
major isomer formed in the vapor phase or ambient air when
volatile organic fluorathene reacts with N2O5 after free
radical formation on the C3 position (Pitts et al., 1985;
Zielinska et al., 1986; Zielinska et al., 1987).
C.  Stucture Activity Relationship (SAR)
Structural features of nitro-PAHs have been investigated
to determine which factors may affect the biological
activity of the compounds (McCoy et al., 1983; Rosenkranz
and Mermelstein, 1983; Klopman and Rosenkranz, 1984; Vance
and Levin, 1984).  Compounds that are good substrates for
nitroreductase activity by bacterial strains often have high
mutagenicity since it is theorized that nitro reduction is
necessary, but not sufficient, for mutagenicity (Vance and
Levin, 1984).  Vance and Levin (1984) have determined that
four factors favor nitro-reduction of the compounds by
Salmonella typhimurium and ultimately enhance the
electrophilic attraction of metabolites to DNA.  The
physical dimensions of the aromatic rings plays a role in
the determination of the mutagenicity of a nitro-PAH.
Compounds with a length of three benzene nuclei are
generally highly mutagenic.  The isomeric position of the
nitro group is important.  If the nitro group is situated
along the long axis of the molecule, mutagenicity is
increased.  When the nitro group and ring system of the
compound are coplanar, mutagenicity is increased.  The
ability of the nitro-PAH to stabilize the final
electrophilic ion by resonance affects the mutagenicity, an
increase in resonance stabilization would be expected to
increase mutagenicity.  Klopman and Rosenkranz (1984) have
linked the presence of certain molecular fragments seen with
nitroarenes to an increase in mutagenicity.
According to the SAR requirements set forth by Vance and
Levin, 3-NFA should be and is a highly mutagenic compound.
It has the optimum length of 3 aromatic rings with the nitro
group oriented along the long axis and coplanar to the rest
of the molecule.  3-NFA also meets the requirements of the
presence of molecular fragments and even though the
stability of the arylnitreniura ion formed from the
metabolism of 3-NFA is unknown, theoretical resonance
structures have suggested that a highly stabilized
electrophile is possible.  At this time, preliminary
investigation is being done concerning the mutagenicity of
2-NFA, a compound that does meet many of the requirements
necessary for mutagenicity.
D.  Metabolism of Nitro-PAHs
Since the metabolic transformations of 3-NFA and 2-NFA
have not been thoroughly investigated, the well
characterized metabolic pathway of 1-NP is believed
representative of the metabolic pathway involved with 2-NFA
and 3-NFA biotransformation.  At this time it is known that
1-NP is activated by both bacterial and mammalian enzymes
(Howard and Beland, 1982; Lehninger, 1975; Andrews et al.,
1986).
D.l.  Bacterial metabolism
The principle metabolites produced from 1-NP
biotransformation by Salmonella typhimurium strains and gut
flora are those derived from the reduction of the nitro
group with addition of six electrons (Howard et al., 1983a.;
Jackson et al., 1985; Andrews et al., 1986; Stanton et al.,
1986).  Nitro-reductases present in the bacterial cell most
likely convert 1-NP to N-hydroxy-1-aminopyrene (via
reduction from l-nitrosopyrene) which is considered the
reactive intermediate responsible for the mutagenic effects
associated with 1-NP.  At this time it is difficult to
isolate this metabolic intermediate due to its high degree
of instability at either ambient or physiological
temperatures (Westra, 1981; Martin et al., 1982; Howard et
al., 1983b.).
Under acidic conditions, the N-hydroxy-1-aminopyrene
yields arylnitrenium ions which can either directly interact
with cellular nucleophiles (including DNA) or rearrange to a
carbonium ion, another highly reactive electrophile capable
of nucleophile reaction with DNA (Karpinsky et al., 1982;
Howard et al, 1983b.; Vance and Levin, 1984; Patton et al.,
1986).  When neutral conditions at room or physiological
temperatures prevail, N-hydroxy-1-aminopyrene is further
reduced to 1-aminopyrene, the fully reduced metabolite of 1-
NP (Messier et al., 1981).
The 1-aminopyrene formed can undergo acetylation to form
N-acetyl-1-aminopyrene via acetyl CoA dependent acetyl
tranferase activity (Orr et al., 1985).  The acetylated
amine product can undergo further activation to form
acetoxyamino groups which are also considered highly
reactive electrophiles (Andrews et al., 1986).
The proposed metabolic pathway of 3-NFA is outlined in
Figure 3 (adapted from Patton et al., 1986).  3-NFA is
reduced to 3-nitrosofluoranthene which is further reduced to
N-hydroxy-3-aminofluoranthene with a subsequent reduction
producing 3-aminofluoranthene (3-AFA), the fully reduced
metabolite.  Under acidic conditions the N-hydroxy-3-
aminofluoranthene can be converted to an arylnitrenium ion.
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the reactive electrophile.  The proposed meta.fc>olism of 2-NFA
is similar to the pathway of 3-NFA with the exception of the
nitro group being positioned on C2 rather than C3 (Figure
4).  3-AFA and 2-aminofluoranthene (2-AFA) are susceptible
to acetylation to form N-acetyl-3-aminofluoranthene (3-
NAAFA) and N-acetyl-2-aminofluoranthene (2-NAAFA).
D.2.  Mammalian Metabolism
D.2.a. Intestinal Gut Flora Metabolism
In many mamalian systems, intestinal gut flora is
considered the major site of in vivo reduction of nitro-PAHs
(Ball and King, 1985).  Bacterial suspensions from rat
intestines have produced 1-aminopyrene from 1-NP (Howard et
al., 1983a.)-  Rats with intact gut flora have been shown to
produce a mutagenic, reduced and acetylated urinary tract
metabolite of 1-NP, 6-hydroxy-N-acetyl-l-aminopyrene (Ball
and King, 1985), while germ free rats were unable to produce
large quantities of the metabolites, 8- and 6-hydroxy-N-
acetyl-1-aminopyrene, indicating intestinal flora is
involved in the metabolism of 1-NP (Ball et al., 1984a.).
During the same experiments it was observed that phenols
were the first metabolites to be excreted followed by
conjugated metabolites some time later, suggesting
enterohepatic circulation may be an important step in the
bioactivation of 1-NP (Ball and King, 1985) .
D.2.b.  Reductive Metabolism
It is well known that eukaryotes have very low levels of
nitroreductase enzymes (Karpinsky et al., 1982).
Nitroreductase activity has been reported in rat hepatic
microsomes (Peterson et al., 1979; Ball et al., 1984a.;
Djuric et al., 1986) and small amounts of reduction of 1-NP
to 1-aminopyrene has been attributed to liver tranformation
in germ free rats (Ball and King, 1985).  In perfused rat
liver. Bond et al. (1984) have also observed reduction
followed by N-acetylation of 1-NP resulting in the formation
of acetylaminopyrine.
Reductive metabolism can indirectly occur in mammalian
species by means of the xanthine oxidase system which is
also able to reduce nitro-PAHs (Howard and Beland, 1982).
Xanthine oxidase is a cytosolic enzyme normally used to
metabolize hypoxanthine (a product of purine base
deamination) to xanthine and then uric acid which in turn is
excreted (Lehninger, 1975).  Each step in the process of
hypoxanthine metabolism involves two electron oxidation
normally requiring the cofactor flavin adenine dinucleotide
(FAD) which acts as the electron acceptor.  Nitro-PAHs can
be reduced by acting as a substitute for FAD, becoming the
electron acceptor. The nitro-PAH enzymatic properties of
xanthine oxidase have been supported by Djuric et al. (1986)
who have determined that xanthine oxidase is able to
catalyze the binding of 3-hydroxy-l-nitropyrene to DNA.
Howard and Beland (1983b.) have also shown that 1-NP binds
10
to DNA in the presence of xanthine oxidase.
D.2.C.  Oxidative Metabolism
Nitro-PAHs can undergo oxidative metabolism resulting in
the epoxidation and hydroxylation of the aromatic ring.  It
is believed that mixed function oxidases found in microsomal
preparations of both rat liver and rabbit lung tissue are
responsible (King et al., 1987; El Bayoumy and Hecht, 1983;
Howard et al., 1985).   When 1-NP is incubated with liver
and lung microsomes, a variety of metabolites are produced
including 1-, 3-, 6-, 8- and lO-hydroxy-1-nitropyrene,
1-aminopyrene, N-acetyl-l-aminopyrene, l-nitropyrene-4,5-
or -9,10-dihydrodiol, l-nitropyrene-4,5- or -9,10-oxide, and
4-, 5-, 6-, 8- or 9-monohydroxy-l-nitropyrene (Ball et al.,
1984; Bond and Mauderly, 1984; King et al., 1984; Djuric et
al., 1986).
1-NP, mutagenic to rabbit tracheal epithelial cells
because of its ability to form 1-NP-DNA adducts, is believed
to be metabolized by both oxidative and reductive pathways
(King et al., 1987).  The reductive metabolites,
1-aminopyrene and N-acetyl-l-aminopyrene, were produced to a
lesser extent than the oxidative metabolites, l-nitro-4,5-
dihydro-4,5-dihydroxypyrene and several hydroxy-1-
nitropyrenes (1-, 3-, 6-, 8- and 10-).  It is important to
note that oxidative metabolites are thought to be more
readily reduced to DNA binding derivatives than the parent
1-NP suggesting their importance in the role of in vivo
production of DNA adducts (Djuric et al., 1986).
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3-NFA has been incubated with Aroclor 1254 treated rat
liver S9 fraction to produce hydroxylated metabolites on at
least 6 of the nine possible positions of the fluoranthene
ring system (Ball et al., 1985; Ball et al., 1987).  The
major metabolites produced appeared to be 8- or 9-hydroxy-3-
nitrofluoranthene and possibly an epoxide whose presence was
suggested upon elution of a phenol, post acid hydrolysis.
3-NFA incubated with rat, mouse, guinea pig or goat
microsomal fractions produced 1-, 6-, 7-, 8-, 9- or 10-
hydroxy-3-nitrofluoranthene (Howard et al., 1988).  The
major metabolites produced in the rat liver were 8- or 9-
hydroxy-3-nitrofluoranthene while the guinea pig fraction
produced mainly 6-hydroxy-3-nitrofluoranthene.  In all
microsomal preparations, minor concentrations of 1-hydroxy-
3-nitrofluoranthene were observed.
The oxidative metabolism of 2-NFA is currently being
studied in this laboratory (unpublished data).  Mammalian
enzyme systems oxidatively metabolize 2-NFA on the benzo
ring distal to the nitro group causing the formation of
2-nitrofluoranthen-8- or -9-ol.   Initial epoxidation may
occur across the C8-C9 bond and is followed by symmetric
rearrangement to the 8- and 9- phenols. An alternative
hypothesis considers the formation of phenols via direct
hydroxylation at the distal end of the molecule.  2-NFA
incubated with S9 liver fraction from Aroclor 1254 treated




nitrofluoranthen-8- and -9-ol (Ball in press, 1986a.)-
Zielenska et al. (1987) have also been able to identify 8-or
9-hydroxy-2-nitrofluoranthene in S9 incubations of 2-NFA.
E. Mutagenicity of Nitro-PAHs
When screened by the Ames assay (Ames et al., 1975), the
mutagenicity of ambient air samples, diesel exhaust, fly
ash, photocopier fluid and cigarette smoke has been
attributed to the presence of direct acting nitro-PAHs
(Nielsen et al., 1984b.; Lofroth, 1980; Lofroth 1980; Pitts,
1983; Lewtas, 1983; Ball et al., 1985; Schuetzle, 1983).
Mutagenicity is frequently reported with the Ames reverse
mutation assay test using a variety of Salmonella
tvphimurium tester strains including TA1538, TA98, TA98 ND,
and TA98/1,8-DNP6 (Ames et al, 1975; Ball et al., 1986b.).
Most nitro-PAHs are considered direct acting mutagens
because they do not require exogenous metabolic activation
(provided by the addition of S9 liver fractions) during the
Ames assay (Ball et al., 1986b.).  Current theory suggests
that nitro-PAHs must be biologically activated by target
cells to induce mutagenicity.  They can be converted by
bacterial nitroreductases to arylhydroxylamines followed by
non-enzymatic conversion to aryl nitrenium ions, highly
mutagenic electrophiles that bind directly to DNA to form
the N-(deoxyguanosin-8-yl)amino-PAH adduct under acidic
conditions (Rosenkranz et al., 1982; Rosenkranz and
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Mermelstein, 1983; Dietrich, 1987).
Some indirect acting nitro-PAHs do require exogenous
oxidative activation by liver S9 preparations containing
mammalian cytochrome P-450 metabolic enzymes (McCoy et al.,
1983).  Nitro-PAHs can be conjugated to form hydroxamic acid
esters that can then be non-enzymatically converted to
arylnitrenium ions.  However, it has been noted that certain
nitro-PAHs are less mutagenic in the Ames assay when S9
liver fraction is added as is the case of 3-NFA and 2-NFA
(Ball et al., 1986b.; Ball, unpublished data).  With some
compounds both reductive and oxidative metabolism are
required for significant mutagenicity, as suggested by an
increase observed in the mutagenic potency of
9-hydroxy-3-NFA in Ames assays (Kirshner, unpublished data).
E.l.   Bacterial Mutagenicity
1-NP has been shown to be moderately mutagenic in
Salmonella tvphimurium strains TA98 (360 - 450
revertants/nmole) with a decrease in mutagenicity seen with
the nitroreductase deficient TA98 ND strain (Wang et al.,
1975).  When metabolized by rabbit lung S9 or Salmonella
bacteria, l-NP produces a number of reduced and oxidized
metabolites most of which produce reversions in the TA98
tester strain with or without the addition of 59 (King
et al., 1984; Andrews et al., 1986).  It is believed that
the 1-nitrosopyrene metabolite of 1-NP is the probable
intermediate in the mutagenicity of the compound which upon
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further reduction with ascorbic acid (a reducing agent)
produces N-hydroxy-1-aminopyrene, a highly reactive
electrophile (Howard et al., 1983a.; Heflich et al., 1985).
Acetylated metabolites of 1-NP have been shown not to bind
to DNA thereby decreasing its potential to induce
mutagenicity (Djuric et al., 1986).
3-NFA is considered highly mutagenic, producing 4,000 -
5,500 revertants/nmole in nitro-reductase capable strains of
Salmonella typhimurium (Griebrokk et al., 1985; Ball et al.,
1986b.).  In nitro-reductase deficient strains such as TA98
ND, 3-NFA is considered slightly mutagenic (Ball et al.,
1985).  Goldring (1986) has shown, however, that with the
addition of zinc dust (a reducing agent) to the incubation,
mutagenic activity was doubled further supporting the need
for nitroreduction before mutagenicity.  The reductive
metabolites of 3-NFA, 3-aminofluoranthene (3-AFA) and
N-acetyl-3-aminofluoranthene (3-NAAFA), were found to be at
least 50 times less mutagenic than the parent 3-NFA with
3-NAAFA requiring exogenous activation to produce any
mutagenicity at all (Ball et al, 1985; Ball et al., 1986b.).
This further supports the theory that the formation of the
arylhydroxylamine is an important intermediate in the
mutagenicity of 3-NFA.
Until recently, not much has been known about the
mutagenicity of 2-NFA.  Our laboratory is involved with
ongoing research studying the mutagenicity of this compound.
In unpublished results, it has been determined that the
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mutagenicity of 2-NFA is of a similar order of magnitude of
that of 1-NP but via a slightly altered pathway.  2-NFA is
considered a slight to moderate mutagen, approximately 5 to
15 fold less mutagenic in the Ames assay than 3-NFA.
2-NFA induces reversions in the three variant strains of
Salmonella typhimurium (TA98, TA98 ND, and TA98/1,8-DNP6)
with lower activity noted in the nitroreductase deficient
strains.  Partial restoration of mutagenic activity was
observed in the nitro-reductase deficient strain TA98 ND
when exogenous activation occured via the presence of S9.
When compared to TA98 ND, TA98/1,8-DNP6 showed an increase
in direct mutagenic activity with an S9 dependent increase
highly noticeable with doses greater than 10 ug/plate.
Ring oxidation of 2-NFA is not believed to be the major
activating step in Ames assays done in the presence of S9
due to the fact that 8- and 9-hydroxy-2-NFA further oxidized
by S9 showed a decrease in mutagenicity (Zielinska et al,
1987).  2-NFA has also been found to be mutagenic towards
strain TM677W in the forward mutation assay in the presence
of S9 consistent with studies done on other nitro-PAH
substances (Ball, 1986b.; Ball, unpublished data; Williams
and Lewtas, unpublished data).
E.2. Mammalian Mutagenicity
Many nitro-PAHs exhibit mutagenic activity in several
mammalian cell assays.  1-NP and l-nitrosopyrene can be
reduced to the reactive electrophile N-hydroxy-1-aminopyrene
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which is a potentially mutagenic compound to Chinese hamster
ovary cells (Heflich et al., 1986).  The electrophile binds
to DNA to form the N-(deoxyguanosin-8-yl)-1-aminopyrene
adduct assaociated with mutagenicity in Salmonella
typhimurium tester strains.  l-NP and 1-nitrosopyrene also
exhibit cytotoxic and mutagenic effects in diploid human
fibroblasts (Patton et al., 1986).
3-NFA, l-NP, and 1,8-dinitropyrene have been found to
cause a dose dependent transformation of Syrian hamster
embryo cells prior to addition of S9 (Dipaolo et al., 1983;
Patton et al., 1986).  2-NFA was inactive and considered not
toxic in the C3H101/2 mammalian cell transformation assay
which is known for its oxidative metabolism of some nitro-
PAHs (Ball, unpublished data).
F.  Carcinogenesis
Chemical carcinogenesis is a complex multistep process
in which damage realized at the molecular level can progress
to cause cancer at the cellular level.  Malignant cells
arise as the result of interactions of genotoxic chemicals
with one or more of the informational molecules of the
target cell (Miller and Miller, 1977; Lutz, 1979; Farber,
1981; Hemminki, 1983).
In many tissues, tumor formation most likely occurs in
two stages.  The first stage is denoted as initiation and is
thought to be the direct assault of the genotoxic substance
on the DNA molecule.  The genotoxic compound can enter the
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organism as the ultimate carcinogen (direct acting) or as a
procarcinogen requiring metabolic activation to a reactive
(electrophilic) species.  These electrophilic species
randomly and non-enzymatically attack cellular nucleophiles
such as RNA, DNA, proteins, lipids, and other cellular
constituents.  When DNA is the target molecule, covalent
attachment occurs forming a DNA adduct which may be
repaired, misrepaired, or remain unchanged thereby causing
DNA conformational alterations.
Promotion, the second step in tumor formation, can occur
immediately after DNA alteration or may require a latency
period of an unspecified length of time.  Eventually,
adducts that have been misrepaired or unrepaired can
transform a cell which can be either recognized as foreign
and removed from the body or proliferate at an abnormal rate
causing malignant or benign tumor formation.
DiPaolo et al. (1983) believe that due to their
ubiquitous distribution and ability to induce morphological
and mutational transformation in both bacterial and
mammalian cells, nitro-PAHs should be considered
carcinogenic.  Malignant and benign tumors of the lung and
liver were observed when eight nitro-PAHs were injected
intraperitoneally into newborn male and female mice
(Wislocki et al., 1986).  Lewtas (1983) reviewed data that
showed diesel exhaust to be carcinogenic in short term
bioassays done to detect oncogenic transformation, viral
enhancement of transformation, and skin tumor initiation.
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Subcutaneous injections of 1-NP given to newborn rats
may have caused the development of malignant tumors both
local and distal to the sight of injection as well as in the
mammary glands of the female rats (Hirose, 1984).  Oghaki et
al. (1982) have determined that 3-NFA and 1-NP may increase
lung carcinomas as well as cause malignant fibrous
histiocytomas at the site of injection.  At this time, very
little data exists on the carcinogenicity of 2-NFA.
However, it is believed that S9 mediated genotoxicity
observed with this compound may be attributed to the
formation of an epoxide (Ball, unpublished data).
G.  Formation of DNA Adducts
The mutagenicity and carcinogenicity of nitro-PAHs have
been attributed to the binding of the electrophilic
intermediates and metabolites to DNA (Dietrich, 1987, Singer
and Grunberger, 1983; van Houte et al., 1987).  Binding of
nitro-PAHs and DNA can cause local distortion of the DNA by
inducing kinking of the helical structure of DNA thereby
inducing enzymatic repair which can lead to mutations if
done incorrectly (van Houte et al., 1987).  Frame shift
mutations also occur when the aromatic moeity of the nitro-
PAH-DNA adduct is intercalated into the DNA helix
(van Houte et al., 1987).
The major adduct formed between nitro- or amino-PAHs and
DNA is the N-(deoxyguanosin-8-yl)-aminopolycyclicaromatic
hydrocarbon adduct which results from the covalent binding
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of the nitrogen atom of the PAH to the C8 atom of
2•-deoxyguanosine (Singer and Grunberger, 1983; Hemminki,
1983; Howard et al., 1983b., Andrews et al., 1986; Dietrich,
1987).  The high electron density at the C8 position of the
deoxyguanosine molecule makes it the most likely site for
attack by electrophilic arylnitrenium ions (Singer and
Grunberger, 1983; Hemminki, 1983).  Several other minor DNA
adducts have been determined by HPLC methodologies and
ͣ^2p-postlabeling but none have been fully characterized
(Gallegher et al., 1987; Dietrich, 1987).
1-NP does not interact directly with DNA to produce DNA
adduct formation but several of its metabolites have
(Mermelstein et al,, 1981; Howard and Beland, 1982; Howard
et al., 1983b.; Djuric et al., 1986; Edwards et al., 1986;
Heflich et al., 1986; King et al., 1987).  When 1-NP was
reduced with xanthine oxidase in the presence of
hypoxanthine and DNA, N-(deoxyguanosin-8-yl)-1-aminopyrene
was produced along with two other minor DNA adducts which
could not be characterized (Howard and Beland, 1982; Howard
et al., 1983b.).  l-nitropyrene-9,10- and -4,5-oxides have
also been observed to bind directly to DNA (Djuric et al.,
1986).  Chinese hamster ovary cells incubated with 1-NP and
1-nitrosopyrene have been shown to produce a single DNA
adduct (N-(deoxyguanosin-8-yl)-aminopyrene) with the
1-nitrosopyrene being more potent than the 1-NP in adduct
formation (Edwards et al., 1986; Heflich et al., 1986).
1-NP metabolites have also been determined to bind to DNA in
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rabbit tracheal epithelial cells (King et al., 1987).
The arylnitrenium ion of the 3-NFA metabolic pathway has
been shown to bind to DNA to form the N-(deoxyguanosin-8-
yl)-3-aminofluoranthene adduct (Dietrich, 1987).  It is
believed that the adduct can then intercalate in the DNA
helical structure to produce frameshift mutations, held
partially responsible for the mutagenicity of 3-NFA (Blake &
Peacock, 1968; Dietrich, 1987).
H.  Analytical Techniques
H.l.   Ames Test
The Ames Salmonella typhimurium assay is commonly used
to screen for mutagenicity (Ames et al., 1975; Maron et al.,
1983; Lewtas, 1983).  Because of the lack of repair
mechanisms in the strains of Salmonella typhimurium TA98
used, the reverse mutation assay responds to frameshift
mutations resulting from base substitutions and frameshifts
caused by xenobiotic assault.  The Salmonella typhimurium
strains normally used have distinct nitroreductase
capabilities unless otherwise stated (Rosenkranz et al.,
1982).  The test is usually done with and without the
addition of an S9 fraction to determine if oxidative
transformation is a necessary step in a compound's
mutagenicity.  The added S9 fraction contains mammalian
mixed function oxidases and requires the coadministration of
a NADPH generating cofactor mix.
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In this study, the Salmonella typhimurium strains that
had been used for a variety of mutagenic screening tests of
3-NFA and 2-NFA were used to determine the metabolic
products formed by each strain.  TA98 is a nitroreductase
competent strain of Salmonella that expresses both
"classical" and "non-classical" nitroreductase activity
(Rosenkranz et al., 1980; McCoy et al., 1981; Rosenkranz et
al., 1982).  The "classical" nitroreductases are responsible
for the metabolism of most nitro-PAHs including nitrofurans,
nitronaphthalenes and nitrofluorenes.  The "non-classical"
nitroreductases may be responsible for the metabolism of
other nitro-PAHs including dinitropyrenes and
nitroacridines.
TA98 ND is a variant of TA98 and is deficient in the
"classical" nitroreductases yet still possesses "non-
classical" nitroreductases and acetyl CoA dependent acetyl
transferases (Rosenkranz et al., 1982; Orr et al., 1985).
TA98/1,8-DNP6 is another variant of TA98 originally
developed for its resistance to 1,8-dinitropyrene (McCoy et
al., 1981).  At first it was thought to be deficient in the
"classical" nitroreductase activity but was later found to
be deficient in acetyl CoA dependent transferase activity
blocking the esterification of arylhydroxylamines to
hydroxamic acid esters (McCoy et al., 1981; McCoy et al.,
1983; Orr et al., 1985).
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H.2.   High Pressure Liquid Chromatography (HPLC)
Reverse phase chromatography is used to separate the
highly polar nitro-PAHs and their metabolites.  A
hydrophobic rather than a hydrophilic column is used for the
stationary phase of the elution process.  HPLC can be used
to qualitatively analyze and separate unidentified compounds
through the comparison of retention times obtained by using
certain columns under specified operating conditions.  HPLC
is most useful when purified standards are available so that
retention times of unknowns can be matched to those of
standards. If standards are coinjected with unknowns and
coelution of both standard and unknown is observed, it is
indicative of structural similarity.
H.3.   Electron Impact Mass Spectrometry (EIMS)
EIMS provides valuable data as to the molecular weight
and molecular structure of an unknown compound.  In EIMS, an
electron beam impinges on a vaporized molecule displacing an
electron (ionizing) and imparting kinetic energy causing
fragmentation.  A fragmentation pattern is created by the
ionized molecules and fragments as they accelerate through a
magnetic field.  Directed onto a detector, this creates a
mass spectrum which is a chemical fingerprint of the sample
(Watson, 1985).  EIMS requires only a few ug of a sample
which must be ionized and vaporized prior to mass analysis.
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H.4.   Proton Nuclear Magnetic Resonance (-^H-NMR)
-' ͣH-NMR aids in the determination of the structure of an
unknown molecule and helps to distinguish between isomers by
determining the number and chemical environment of the
protons of the unknown.  It does this by determining the
resonance frequency of the protons, the frequency at which a
proton absorbs a quantum of energy causing it to change its
orientation with respect to an applied magnetic field.
Protons in different magnetic environntents will resonate at
different frequencies while protons in comparable
environments will resonate at similar frequencies.  ^H-NMR
requires at least 100 ug of an unknown sample to generate
acceptable spectrum.
I.  Summary
3-NFA and 2-NFA are wide spread environmental pollutants
that have been determined to be mutagenic and possibly
carcinogenic in both mammalian and bacterial assays.
Because of the potential human exposure to high
concentrations of these substances, investigations need to
be conducted to elucidate mechanisms of metabolism.  The
purpose of this study is to analyze the reductive
metabolites of these compounds formed by three variant
strains of Salmonella typhimurium (TA98, TA98 ND and
TA98/1,8-DNP6) and to investigate a possible metabolic basis
for differences in mutagenic potency between the variants of
Salmonella typhimurium and isomers of nitrofluoranthene.
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III.       MATERIALS   AND   METHODS
A-  Materials
3-nitrofluoranthene was synthesized and characterized by
Midwest Research Institute (Kansas City, MO).  Radiolabeled
3-nitro-[-'-^C ]-f luoranthene of 13.8 mCi/mMole specific
activity and +99% purity was custom synthesized by Midwest
Research Institute.  3-aminofluoranthene standard was
purchased from Aldrich Chemical Company (Milwaukee, WI).
2-nitrofluoranthene was synthesized by Dr. Louise Ball
from 3-aminofluoranthene (Aldrich Chemical Company) as
described (Kloetzel et al., 1955).  The purity of the
compound was verified by HPLC and thin-layer chromatography.
2-nitro-[-^H]-fluoranthene was purchased from Chemsyn Science
Laboratories (Lenexa, KS).  2-aminofluoranthene was produced
from the chemical reduction of 2-nitrofluoranthene (Dr.
Louise Ball).  N-acetyl-2-aminofluoranthene was obtained
from the acetlyation of synthetic 2-aminofluoranthene and N-
acetyl-3-aminofluoranthene was obtained from the acetylation
of 3-aminofluoranthene (Dr. Louise Ball).
HPLC grade methanol, ethyl acetate, and acetone were
purchased from Fisher Scientific (Fairlawn, NJ).
Scintiverse E liquid scintillation cocktail was purchased
from Fisher Scientific.  Baker analyzed grade dimethyl
sulfoxide was purchased from Baker Chemical Company
(Phillipsburg, NJ).  Deuterated acetone (isotropic purity
100 atom %) was purchased from Aldrich Chemical Company
(Milwaukee, WI).
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Double distilled water was from the central water
distribution system at Lineberger Cancer Research Center.
Distilled, deionized, carbon-filtered distilled water from
an all glass and teflon still was used for chromatography
and obtained at the Lineberger Cancer Research Center.
Oxoid Nutrient Broth #2 was obtained from Oxoid Limited
(Basingstoke, Hants., England or Columbia, MD). Salmonella
typhimurium strain TA98 was obtained from Dr. Bruce Ames
(University of California, Berkeley). Salmonella
typhimurium strains TA98 ND and TA98/1,8-DNP6 were obtained
from Dr. H. S. Rosenkranz (Case Western Reserve University,
Cleveland, OH).
B.  Methods
B.l.  In Vitro Metabolism of 3-NFA by Salmonella typhimurium
Five 20 ml cultures per strain of Salmonella typhimurium
TA98, TA98 ND, and TA98/1,8-DNP6 in nutrient broth (25g
Oxoid Nutrient Broth #2 in 1 liter double distilled water,
pH 7.5) were incubated for 16 hours at 37°C in a dry air
shaker to reach a cell density of approximately 1.4 x 10^ to
1.6 X 10^ cells/ml (Dr. Ball, preliminary data).
To each 20 ml culture, 8 ul of 10 mM S-nitro-cl'^C]-
fluoranthene in DMSO was added for a final incubation
concentration of 4.0 uM with approximately 2.5 x 10^ dpm per
culture.  All five treated cultures were then incubated at
37°C in a dry air shaker in sealed vials with minimal head
space.  At 0.5, 1, 2, 3, and 6 hour intervals, one culture
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was removed and immediately extracted with 20 ml ethyl
acetate/acetone (2:1, v/v) three times for a total of 60 ml.
All experiments were carried out in duplicate.
Controls were done by incubating 8 ul of 10 mM 3-nitro-
[^^C]-fluoranthene in 20 ml of nutrient broth for 6 hours at
37°C (dry air shaker) prior to ethyl acetate/acetone
extraction.
B.2.  In Vitro Metabolism of 2-NFA by Salmonella typhimurium
Five 20 ml cultures per strain of Salmonella typhimurium
TA98, TA98 ND, and TA98/1,8-DNP6 (grown in the same manner
as previously described) were incubated with 8 ul of 10 mM
2-nitro-[-^H]-fluoranthene in DMSO for a final concentration
of 4.0 uM, 8.0 x 10^ dpm per culture (37°C, dry air shaker).
At 0.5, 1, 2, 3, and 6 hour intervals, one culture was
removed and immediately extracted with ethyl
acetate/acetone.  All samples were done in duplicate.
Two additional 24 hour incubations (37°C, dry air
shaker) were done for each strain of Salmonella typhimurium
at concentrations of 4.0 uM (8.0 x 10^ dpm per culture)
2-nitro-[-^H]-fluoranthene.  At the end of incubation the
cultures were immediately extracted with ethyl
acetate/acetone.
Five 20 ml Salmonella typhimurium TA98 cultures were
incubated with 40 uM 2-nitro-[-^H]-f luoranthene for 24 hours
at 37°C (dry air shaker).  They were immediately extracted
with ethyl acetate/acetone upon removal.
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Controls were done by incubating 8 ul of 10 iriM 2-nitro-
[ ͣ^H]-fluoranthene in 20 mis of nutrient broth for 24 hours
at 37°C (dry air shaker) prior to ethyl acetate/acetone
extraction.
B.3.  Extraction of 3-NFA and 2-NFA Salmonella typhimurium
Incubations
The whole incubate was combined with  1 volume of ethyl
acetate/acetone 2:1, v/v (HPLC grade) in a 50 ml capped
centrifuge tube, inverted, and centrifuged at 1000 rpm for 5
minutes.  The organic layer was removed and set aside.  The
extraction procedure was repeated twice to give a total
organic pool of 3 x 1 volume of the original (60 ml).  The
extracts were evaporated to dryness on a rotary evaporator
(Buchi Rotavapor TM, Flawil, Switzerland) and resuspended in
10 ml methanol (HPLC grade).  Samples were then filtered
through a C^s ^ep Pak cartridge (Millipore Corp., Bedford,
Ma) and evaporated to dryness under a stream of nitrogen
prior to reconstitution with 1 ml methanol for a final
concentration of approximately 1 uCi/ml for 3-NFA and 3
uCi/ml 2-NFA samples.   When necessary, extracts were stored
at -60° C.
NOTE;  Prior to each step in the extraction process, 2 x 0.1
ml of the original incubate and the resulting extraction
fractions were aliquotted into scintillation vials for
determination of radioactive content and percent recovery.
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B.4.  High Pressure Liquid Chromatography
Separation and purification of metabolites were done
using a Varian LC-5000 (Palo Alto, CA) equipped with a six
port Rheodyne injector using 20, 100 or 500 ul injection
loops.  Reverse phase Zorbax ODS columns (DuPont
Instruments, Wilmington, DE) fitted with a 4.6 x 50 mm
pellicular ODS precolumn were used for analytical
separations (4.6 x 250 mm column) and preparative
separations (9.4 x 500 mm column).  Normal operating
pressure for both columns was between 50 and 220 atm.
HPLC effluent was monitored at 2 54 nm using a Perkin-
Elmer LC-85B Spectrophotometric Detector with an LC-85
autocontrol (Norwalk, CT), a dual beam variable wavelength
detector with an 8 ul flow cell capable of detecting
wavelengths between 190 and 600 nm as well as scanning
spectra of selected chromatographic peaks.  The instrument
was operated at sensitivities of 0.16 to 0.64 absorbance
unit maxima.  For single wavelength monitoring, data were
output to a Spectrophysics SP4270 Integrator (Piscataway,
NJ).  Stop flow scanning spectra between the wavelengths of
250 to 450 nm were recorded on a Perkin-Elmer 561 recorder.
Since samples were radiolabeled, qualitative and
quantitative analysis was done using an ISCO Retriever III
fraction collector (Lincoln, NE).  Thirty second fractions
of HPLC effluent were collected in 20 ml scintillation vials
for determination of ^'^C and -^H content by liquid
scintillation counting after the addition of 10 ml
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Scinteverse E scintillation cocktail.
Two different HPLC gradient programs were used to
separate the metabolites and parent compound present after
incubation.
Program I:  Separation of 3-NFA and its metabolites 3-AFA
and 3-NAAFA
0 to 3 minutes:  3 0% water  70% methanol
3 to 18 minutes: 30% water  70% methanol to 0% water
100% methanol
18 to 2 3 minutes: 0% water  100% methanol
23 to 28 minutes: 0% water  100% methanol to 30% water
70% methanol
Flow:  Analytical Column:  1 ml/minute
Preparative Column:  4 ml/minute
Program I:  Separation of 2-NFA and its metabolites 2-AFA
and 2-NAAFA
0 to 20 minutes: 30% water 70% methanol
20 to 25 minutes: 30% water  70% methanol to 0% water
100% methanol
25 to 30 minutes: 0% water  100% methanol
30 to 35 minutes: 0% water  100% methanol to 30% water
70% methanol
Flow:  Analytical Column:  1 ml/minute
Preparative Column:  4 ml/minute
Chromatographic fractions were collected manually based
on UV absorption peaks.  The fractions were dried by
evaporation under a stream of nitrogen and stored at -60° C.
B.5.  Liquid Scintillation Counting
Samples were counted on an LKB-Wallace Betarack Liquid
Scintillation Counter (Model 1217) equipped with a 1217-101
DPM package.  10 ml of Scintiverse E were added to the
samples deposited in 20 ml standard glass scintillation
vials.  Vials were counted for five minutes on the preset
30
^^c channel (for l'*C-3-NFA) and ^H channel (for 3h-2-NFA) .
The 1217-101 DPM package allows for the conversion of
counts per minute (cpm) to disintegrations per minute (dpm).
A calibration curve for -^^C was obtained by preparing eight
replicates containing 10,000 dpm -' ͣ'^C toluene in 10 ml
Scinteverse E and then adding progressively greater amounts
(by multiples of 10) of nitromethane, a quenching agent.
The samples were then counted for five minutes and an
automatic spline function was used to generate a "best fit"
calibration curve.  A calibration curve for -^H was obtained
in the same manner by substituting -^H toluene for ^^C
toluene.  Unquenched ^'^C samples were counted with
approximately 90% efficiency while unquenched -^H samples
were counted with approximately 3 0% efficiency.
B.6.  Mass Spectrometry
Mass spectrometry was done using the VG 70-250 SEQ
Tandem Hybrid MS/MS (Vacuum Generator, Altrincham, Cheshire,
England) operated at 70eV.  The direct probe temperature was
ramped manually from approximately 3 0°C to 3 00°C as quickly
as possible.  1 to 3 ug of each metabolite produced by each
Salmonella typhimurium strain was analyzed prior to pooling
of metabolites.
Normally, the relative intensity of ions and ion
fragments are assumed consistent within a single compound
and are therefore often used as a diagnostic tool in MS.
However, with many nitro-PAH, considerable variability in
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ion fragment intensities have been attributed to varying
sample concentrations and instrument conditions disallowing
the use of this technique for identification purposes.
B.7.  Nuclear Magnetic Resonance (NMR)
The Varian XL400 Instrument housed in the UNC Chemistry
Department was the source of all proton NMR spectra.
Similar metabolite samples were pooled to obtain
approximately 120 ug of each metabolite for NMR analysis.
Purified metabolites were dissolved in 1 ml deuterated
acetone and scanned from 0 to 10 ppm.  Chemical shifts were
reported in ppm, downfield from tetramethyl silane (TMS)
with coupling constants (J) reported in Hz.
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IV.  RESULTS
A.  Separation and Identification of 3-NFA and Its
Metabolites
A.l.  Separation
Extraction methods employed returned 85.5% of the
14c-3NFA incubated with TA98 while 87.4% and 91.9% of the
radiolabeled material was recovered from TA98 ND and
TA98/1,8-DNP6, respectively.  The remainder of the
radioactivity was accounted for in the aqueous phase of the
extraction.
HPLC fractionation was accomplished by injecting 20 ul of
each of the incubation extracts onto a Zorbax ODS analytical
column using Program I (1 ml/minute).  TA98, TA98 ND and
TA98/1,8-DNP6 produced two compounds eluting at 11.2 and 21
minutes.  These will be referred to as fraction 1 and
fraction 2 respectively.  A representative chromatogram
(absorption 254 nm) is presented in Figure 5.  Parallel
controls produced one peak eluting at 21 minutes.
To ensure that fraction 1 was not composed of two or more
coeluting compounds under Program I gradient conditions, 2 0
ul of the TA98 6hr incubation was fractionated under the
conditions of Program II.  Only one peak eluted, at 12.2
minutes (Figure 6).
A.2.  Primary Identification
The retention time of fraction 1 was similar to that of
the unlabeled 3-AFA standard.  When 2 0 ul of the extracted
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incubations from TA98, TA98 ND and TA98/1,8-DNP6 were
coinjected with unlabeled 3-AFA standard, fraction 1 coeluted
with the standard suggesting its identity.  Fraction 1
produced a U.V. spectrum (when scanned between 2 50 and 4 50
nm) with maximum absorption at 300 nm with an additional
broad peak at 370 nm.  This resembled the spectrum of the
3-AFA standard under similar conditions (Figure 7).
Fraction 1 also fluoresced yellow under long wave ultraviolet
light (365 nm).
The retention time of fraction 2 was similar to that of
the unlabeled 3-NFA standard.  When extracted incubations
were coinjected with unlabeled 3-NFA, fraction 2 coeluted
with the standard.  Fraction 2 had a U.V. spectrum with
absorption peaks at 254 and 265 nm a broad peak between 370
and 390 nm.  The spectrum was similar to that of the 3-NFA
standard (Figure 8).
A.3.  Quantitation
Quantitative analysis of the production of fraction 1 was
made possible through the use of ^'^C-3NFA and collection
followed by counting of 3 0 second aliquots of eluant over a
thirty minute period.  The radioactivity profiles obtained
from the injection 20 ul of the extracted incubations
(approximately 40,000 DPM) were similar and corresponded to
the chromatograms produced by absorption at 2 54 nm
(Figure 9).
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The curve representing TA98's production of fraction 1 (as
percent radiolabeled metabolite) is presented in Figure 10
(Table 1).  Metabolite production appears to follow first
Oder kinetics.  Within the first half hour, 30.1% of the
parent compound had been converted to fraction 1 followed by
48.9%, 68.6% and 77.9% conversion at 1, 2, and 3 hours
respectively.  By 6 hours, 97.2% of the radiolabeled material
was present in fraction 1.
Figure 11 (Table 2) represents the metabolic curve
produced by TA98 ND over the 6 hour incubation period.  The
metabolism of the parent compound appears to be slower than
that in TA98 yet still appears linear with respect to time.
At 1 hour, only 16.6% of the original radiolabeled compound
had been converted to fraction 1 with 34.9% of the
radioactivity present in the fraction at 2 hours and 47.3%
present at 3 hours.  By 6 hours, 92.9% of the original
radiolabeled compound had been converted to fraction 1.
The metabolic curve produced by TA98/1,8-DNP6 is
presented in Figure 12 (Table 3) and is similar to that of
TA98.  Once again, metabolite production appears linear with
respect to time for the first two hours of incubation
converting to first order kinetics some time after the that.
At 0.5 hours, 39.6% of the original radiolabeled material was
converted to fraction 1.  At 1, 2 and 3 hours, 51.9%, 73.7%
and 85.4% of the radioactivity eluted in fraction 1.  By 6
hours, 95.6% of the radioactivity had been converted into
fraction 1.
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A.4.  Secondary Identification
Upon separation of fractions 1 and 2 using HPLC
methodologies employing the Zorbax ODS preparative column and
Program I (4 ml/minute), respective fractions from all
incubations were pooled for mass spectrometry and NMR
evaluation.  159 ug of fraction 1 was available for analysis
while 150 ug of fraction 2 was collected.
A.4.a.  Mass Spectrometry (MS)
The mass spectrum produced by 2 ug of fraction 1 is
presented in Figure 13.  The signal at M/z 217 is the mass
expected for the molecular ion (M+) of 3-aminofluoranthene.
M/z 202 is believed to be a fragmentation product of M+,
M-NH.  M/z 189 may also be the fragmentation product M-CNH2.
M/z 229 and M/z 243 are contaminants (shown by examination of
single ion chromatograms), possibly hydrocarbons due to
column breakdown or the presence of plasticizers.
The mass spectrum produced by 2 ug of fraction 2 is
presented in Figure 14.  The signal at M/z 247 is consistent
with the mass for the M+ of 3-nitrofluoranthene.  M-0 (M/z
231), M-NO (M/z 217), M-NO2 (M/z 203) and M-CNO2 (M/z 189)
are common fragmentation peaks seen with many nitro-PAHs
(Henderson et al., 1983; Schuetzle and Jensen, 1985).
M/z 313 and M/z 385 are believed to be contaminants of
hydrocarbon chains (shown by examination of single ion
chromatograms).  Based upon this information, as well as the
U.V. spectrum and elution factors obtained on this fraction,
fraction 2 is the parent compound, 3-nitrofluoranthene.
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A.4.b.  NMR of Fraction 1
The NMR sprectrum of fraction 1 is presented in
Figure 15. Chemical shifts, reported in parts per million
(ppm) downfield from the standard tetramethyl silane (TMS),
and coupling constants (J), reported in Hz, are summarized in
Table 4.
8.15 ppm
Doublet, integrated as one proton with J]^ 2 ~ ^.0 Hz.  H-1, a
pseudo-bay region proton expected to be downfield in the same
approximate region as H-6, H-7 and H-10.
8.05 ppm
Doublet, integrated as single proton with J5 g = 6.8 Hz.
H-6, a pseudo-bay region proton expected to be downfield with
H-1, H-7 and H-10 and coupled to H-5.
7.95 ppm
Split doublet, integrated as one proton with Jy 3 ~ ^'^ ^^
and Jy ]^o ~  '^•^ H2.  H-7, a pseudo-bay region proton expected
to be downfield with H-1, H-6 and H-10 and coupled to H-8.
The J observed is also similar to H-10, located para the
proton and responsible for the fine splitting observed.
7.80 ppm
Doublet, integrated as one proton with J4 5 = 8.3 Hz.  H-4,
located peri to the amino group and coupled to H-5.  Located
downfield.
7.78 ppm
Split doublet, integrated as single proton with
Jg 3^0 = "7-5 Hz and J7 10 =0-9 Hz.  H-10, a pseudo-bay region
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proton expected to be downfield with H-1, H-6 and H-7 and
coupled to H-9.  The J observed is also similar to that of
its para proton, responsible for the fine splitting observed.
7.58 ppm
Triplet, integrated as one proton with J5 g = 6.9Hz and
J4 5 = 8.3 Hz.  H-5, coupled with H-4 and H-6.
7.31 ppm
Split triplet, integrated as single proton with
Jy 3 = 7.5 Hz, Jg 9 = 7.5 Hz and Jg ^q  =   1.1 Hz.  H-8,
coupled with H-9 and H-7.  Split peaks observed are due not
only to the neighboring effects of H-9 and H-7 but also from
H-10 located across the aromatic ring.
7.22 ppm
Split triplet, integrated as one proton with Jg 9 = 7.5 Hz,
J9 10 ~ ^-5 ^2 and J7 9 = 1.1 Hz.  H-9, coupled with H-8 and
H-10.  Split peaks observed are due not only to the
neighboring effects of H-8 and H-10, but also from H-7
located across the aromatic ring.
6.80 ppm
Doublet, integrated as one proton with J^ 2 ~ ^'^ ^^'   H-2,
normally located downfield of all other protons due to the
electron-withdrawing capacity of the nitro group on the
parent 3-NFA, but now shifted upfield due to the reduction of
the nitro group to an amino group.
The amino protons can occur anywhere in the spectrum and
are often difficult to locate because of exchange broadening.
Amino groups can exchange with the solvent used for NMR
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analysis, but to a much lesser extent than has been observed
with hydroxyl groups.
The NMR spectrum, MS spectrum, U.V. spectrum and elution
factors of fraction 1 identify it as
3-aminofluoranthene.
B.  Separation and Identification of 2-NFA and Its
Metabolites
B.l.  Separation
Extraction methods recovered 85.1% of the radiolabeled
material incubated with TA98, 84.5% incubated with TA98 ND
and 92.5% incubated with TA98/1,8-DNP6.
HPLC fractionation used the Zorbax ODS analytical column
and Program II (1 ml/minute).  TA98 and TA98 ND produced
three compounds eluting at approximately 12.2, 13.6 and 2 5.3
minutes and referred to as fraction A, B, and C respectively.
A representative chromatogram (absorption 2 54 nm) is
presented in Figure 16.  The fractionation of TA98/1,8-DNP6
produced only fractions A and C (Figure 17).  Parallel
controls produced one peak eluting at 25.3 minutes.
B.2.  Primary Identification
The retention time of fraction A was similar to that of
the 2-AFA standard.  When 2 0 ul of the extracted incubations
of TA98, TA98 ND and TA98/1,8-DNP6 were coinjected with
unlabeled 2-AFA standard, fraction A coeluted with the
standard suggesting its identity as 2-AFA.  Fraction A had a
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U.V. spectrum with maxima at 250 nm and an additional peak at
280 nm.  A broader, multi-band peak was also observed between
330 and 380 nm.  The spectrum was similar to that of the 2-
AFA standard (Figure 18).  Fraction A was also fluorescent
producing a blue-green fluorescence when placed under long
wave ultra violet light (365 nm).
The retention time of fraction B was similar to that of
the unlabeled 2-NAAFA standard.  When extracted TA98 and
TA98 ND samples were coinjected with unlabeled 2-NAAFA,
fraction B coeluted with the standard.  A well resolved U.V.
spectrum of fraction B was difficult to produce due to its
low concentration in the samples.  However, the crude
spectrum produced resembled the spectrum obtained from the
standard (Figure 19).  A maximum was oberved at 2 54 nm with
two lesser peaks at 273 and 294 nm.  A broad multi-band peak
was located between 320 and 380 nm.
The retention time of fraction C was similar to that of
the unlabeled 2-NFA standard.  Upon coinjection with
unlabeled 2-NFA standard, fraction C of TA98, TA98 ND and
TA98/1,8-DNP6 coeluted with the standard.   U.V. scanning
fraction C gave a spectrum comparable to the standard with
maximum absorption seen at 260 nm (Figure 20).  An additional
peak was observed at 290 nm with a broad multi-band peak
located between 3 30 and 380 nm.
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B.3.  Quantitation
Quantitative analysis of the production of fractions A
and B from fraction C was made possible through the use of
ͣ^H-2NFA.  The radioactivity profiles were obtained for 20 ul
of each of the extracted incubations (approximately 120,000
DPM).  Figure 21 represents the profile obtained for TA98 and
TA98 ND, compared to the chromatogram produced by absorption
at 254 nm.  Figure 22 compares the radioactivity profile of
TA98/1,8-DNP6 to the chromatogram produced at 254 nm.
The apparent rate of metabolism of fraction C by all
three strains of Salmonella typhimurium was greatly reduced
when compared to that of fraction 2 (3-NFA).  The metabolite
profile obtained with TA98 is presented in Figure 2 3 (Table
5) and appears to be linear with respect to time through the
first six hours of incubation converting to first order
kinetics some time after that.  Through the first 6 hours,
41.6% of the radioactivity eluted as fraction A.  When
incubation was carried through for 24 hours, 78.7% of the
radioactivity was eluting as fraction A.  The kinetics of the
reaction from 6 to 24 hours can not be determined withiut
additional time points taken between 6 and 24 hours.  The
enzyme activity responsible for the production of fraction B
from fraction A appears to be linear with respect to time
with saturation of the enzyme occurring between 6 and 24
hours.  By the end of the sixth hour of incubation, 10.9% of
the radioactivity eluted as fraction B. 15.9% of the
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radioactivity eluted as fraction B 24 hours after the
initiation of incubation.
The metabolic profile of TA98 ND presented in Figure 24
(Table 6) reveals that only 6.2% of the radiolabeled material
was converted to fraction A (2.7%) and fraction B (3.5%) by
the sixth hour of incubation.  After 24 hours of incubation,
80.1% of the radioactivity eluted in fraction A with 14.6%
eluting in fraction B.  Minimal production of both fractions
is observed through the first six hours of incubation with a
sharp increase seen in the production of fraction A between 6
and 24 hours.  The production of fraction B also increased
during this period.  The kinetics of the enzyme activity are
difficult to determine without additional time points between
6 and 24 hours.
TA98/1,8-DNP6 produced a metabolic profile presented in
Figure 25 (Table 7).  It was able to convert 13.3% of the
radiolabeled material to fraction A within the first 6 hours
of incubation.  After 24 hours of incubation, 91.7% of the
radioactivity was eluting in fraction A.  The kinetics of the
enzyme activity of TA98/1,8-DNP6 appear to be linear with
respect to time through the first three hours of incubation,
but additional concentrations of subtstrate and time points
between 6 and 2 4 hours are needed to determine its exact
kinetics.
In order to increase the amounts of fractions A and B,
the concentration of 3h-2NF incubated with TA98 was increased
10-fold.  At the end of the incubation period, 22.5% (8.82
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umoles) of the radiolabeled material had been converted to
fraction A and 1.7% (0.68 umoles) eluted in fraction B.  The
previous 24 hour incubations of 4.0 umoles of •^H-2NF produced
3.15 umoles of fraction A and 0.64 umoles of fraction B.
These numbers suggest the saturation of the nitroreductase
enzymes and trans-acetylase enzymes found in TA98 as
previously hypothesized.
B.4.  Secondary Identification
Upon separation of fractions A, B and C by HPLC using the
Zorbax ODS preparative column and
Program II (4 ml/minute), respective sample fractions from
all strains and time points were pooled for MS and NMR
analysis.  146 ug of fraction A was collected as well as 6.5
ug of fraction B.  213 ug of fraction C was also available
for analysis.
B.4.a.  Mass Spectrometry
MS of 2 ug of fraction A gave the spectrum presented in
figure 26.  The peak at M/z 217 represents the mass expected
for M+ of 2-aminofluoranthene.  The fragmentation product at
M/z 200 represents M-NH2.  M-CNH2 (M/z 189) is also a
possible fragmentation product.  M/z 229 and M/z 243 are
possible hydrocarbon contaminants.
Two ug of fraction B gave the mass spectrum presented in
figure 27.  The signal at M/z 259 is consistent with the mass
expected for M+ of N-acetyl-2-aminofluoranthene.  M/z 217 is
a fragmentation product of M-C2H2O with M/z 2 00 representing
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M-NC2H4O.  M-NC3H4O (M/z 189) may also be a fragmentation
product.  Contaminants of M/z 229 and M/z 243 are also
present.  This information along with the coelution factor
and U.V. spectrum data favors the identification of fraction
B as N-acetyl-2-aminofluoranthene.  2-NAAFA was isolated in
quantities too low to permit definitive identification by NMR
analysis.
MS of 2 ug of fraction C gave the spectrum presented in
figure 28.  The signal at M/z 247 is consistent with the mass
expected for the M+ of 2-nitrofluoranthene.  M/z 231, M/z
217, M/z 201, and M/z 189 represent the fragmentation
products M-0, M-NO, M-NO2, M-CNO2, respectively.  These are
common fragmentation products of nitro-PAHs.  This
information as well as the U.V. spectrum and the elution
factors identifies fraction C as 2-nitrofluoranthene.
B.4.b.  NMR of Fraction A
The NMR spectrum of fraction A is presented in
figure 29.  The spectrum was not as strong as that of 3-AFA
because of the smaller amount of fraction A available for NMR
analysis.  Chemical shifts and coupling constants that were
identifiable are summarized in Table 8.
7.93 ppm
Multiplet, integrated as one proton with J7 q  = 7.7 Hz and
J7 10 ~ ^•'4 ^z.  H-7, a pseudo-bay region proton coupled with
H-8 and located downfield with H-1, H-6 and H-10.  The J
observed is similar to that of H-10, located para to the
proton and contributing to the splitting observed in H-7.
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7.90 ppm
Multiplet, integrated as one proton with Jg iq  =  7.5 Hz and
J-7 20 ~ ^'^  ^^ •  H-IO, a psuedo-bay region proton coupled
with H-9 and located downfield with H-1, H-6 and H-7.  The J
observed is similar to that of its para proton, H-7.
7.72 ppm
Doublet, integrated as single proton with J5 g = 6.7 Hz.
H-6, a pseudo-bay region proton coupled to H-5.  Located
downfield in the same approximate region as H-1, H-7 and
H-10.
7.59 ppm
Meta-coupled singlet, integrated as single proton with
J = 1.7 Hz.  H-1, pseudo-bay region proton ortho to the amino
group and located downfield with H-6, H-7 and H-10.  The fine
splitting seen is due to its proximity to the amino group.
7.58 ppm
Doublet, integrated as single proton with J = 6.5 Hz.  H-4,
coupled with H-5 (J = 6.8, 6.6 Hz).
7.50 ppm
Triplet, integrated as a single proton with J = 6.8, 6.6 Hz.
H-5, coupled with H-4 (J = 6.5 Hz) and H-6 (J = 6.7 Hz).
7.36 ppm
Super-imposed triplets, integrated as two protons with
J = 7.5, 1.7 Hz.  H-8 and H-9, coupled to H-7 (J = 7.7,
1.4 Hz) and H-10 (J = 7.5, 1.4 Hz), respectively.
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6.99 ppm
Meta-coupled singlet, integrated as a single proton with
J = 1.6 Hz.  H-3, a proton located ortho to the amino group
and upfield from the remaining protons of the molecule.
This information as well as the information gathered
from MS, U.V. spectra and coelution factors, identifies
fraction A as 2-aminofluoranthene.
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V.      DISCUSSION
The bacterial metabolism of 1-NP, isomeric with
nitrofluoranthene, has been extensively characterized.
Salmonella typhimurium strain TA98 produced two major
metabolites of 1-NP, 1-aminopyrene and N-acetyl-1-
aminopyrene, and six minor metabolites (Messier et al.,
1981).  Howard et al. (1983) identified 1-aminopyrene as the
major metabolite produced by incubating 1-NP with
suspensions of bacteria from rat intestines.
Little information has been published on the bacterial
metabolism of 3-NFA and 2-NFA.  In this study, when 3-NFA
was incubated with Samonella typhimurium strain TA9 8 and its
variants TA98 ND and TA98/1,8-DNP6, one metabolic product
was obsereved, 3-AFA.  When 2-NFA was incubated with the
same strains of Salmonella typhimurium. two metabolic
products were produced, 2-AFA and 2-NAAFA.
A.  Separation and Identification of 3-NFA and Its
Metabolites
HPLC and radioactivity profiles of extracted medium from
incubations of 3-NFA and Salmonella typhimurium strains
TA98, TA98 ND, and TA98/1,8-DNP6 indicated the production of
one metabolite which was identified as 3-AFA (Figure 5).
All three strains of Salmonella typhimurium were able to
metabolize over 90% of the parent compound present within
six hours of the initiation of incubation.  The production




TA98 possesses both "classical" and "non-classical"
nitroreductive enzymes as well as transacetylase enzymes
(Rosenkranz et al., 1980; McCoy et al., 1981; Rosenkranz et
al., 1982).  The strain is able to accomplish the conversion
of 3-NFA to 3-AFA in a relatively rapid manner.  The
metabolic profile of TA98 appears to approach saturation at
six hours (Figure 10, Table 1).  Additional experiments with
varying concentrations of substrate are needed to determine
the exact enzyme kinetics of the reaction.
The conversion of 3-NFA to 3-AFA by TA98 ND proceeds at
a slower, more linear rate than that observed with TA98
(Figure 11, Table 2).  TA98 ND is deficient in the
"classical" nitroreductases associated with rapid conversion
of many nitro-PAHs to their metabolic products and is
resistant to the mutagenic activity of those nitro-PAHs
(Rosenkranz et al., 1982; Orr et al., 1985).  The reduction
of 3-NFA to 3-AFA in this strain is therefore dependent upon
the enzyme activity of the "non-classical" nitro-reductive
enzymes.  These "non-classical" nitroreductases may react at
a slower rate than the "classical" enzymes or may work in
harmony with the "classical" reductases in an additive or
synergistic manner.
TA98/1,8-DNP6, possessing both "classical" and "non-
classical" reductive capacity (McCoy et al., 1981; McCoy et
al., 1983; Orr et al., 1985), was able to convert 3-NFA to
3-AFA at a rate similar to TA98 (Figure 12, Table 3).  Once
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again, the profile appears to be approaching saturation.
3-AFA was identified as the principle metabolite by
HPLC, MS, and proton NMR analysis.  Relative retention times
and coelution with unlabeled 3-AFA standard suggested the
identity of the metabolite early on.  Further proof was
obtained upon comparison of U.V. spectra of the compound and
standard (Figure 7).  MS of the pooled metabolite gave a
molecular ion with the weight of 217, expected for 3-AFA
(Figure 13).  Identification of fragmentation products of
M-NH (M/z 202) and M-CNH2 (M/z 189) was also possible.
Fragmentation products of this type have also been seen with
nitro-PAH (Schuetzle, 1985).  NMR spectrum of the fraction
verified the presence of the nine aromatic protons expected
for 3-AFA.  Present were three triplets (H-5, H-8 and H-9)
and six doublets (H-1, H-2, H-3, H-4, H-6, H-7 and H-10)
with coupling constants between 7 to 8 Hz, indicative of
aromatic protons (Silverstein et al., 1981).
B.  Separation and Identification of 2-NFA and Its
Metabolites
Salmonella typhimurium strains TA98, TA98 ND and
TA98/1,8-DNP6 were unable to metabolize 2-NFA as quickly as
3-NFA.  Six hour incubations produced insufficient
metabolite for identification.  An additional time point of
24 hours was needed to produce the minimum amount of
metabolite required for analysis.
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HPLC and radioactivity profiles of extracted medium from
incubations of 2-NFA with Salmonella tvphimurium TA98 and
TA98 ND indicated the production of two metabolites
identified as 2-AFA and 2-NAAFA (Figure 16).  2-NFA
incubated with TA98/1,8-DNP6 produced only one metabolite,
2-AFA (Figure 17).
Approximately 63% of the parent compound had been
converted into 2-AFA and 2-NAAFA by TA98 within the first
six hours of incubation (Figure 23, Table 5).  However, by
24 hours, 95% of the 2-NFA had been converted into the
metabolites (79% 2-AFA and 16% 2-NAAFA).  The production of
2-AFA by TA98 confirms the presence of reductive pathways in
the strain.  The 2-NAAFA produced by the strain was a
product of the acetylation of the 2-AFA by acetyl CoA
dependent acetyl transferases found in TA98 and TA98 ND
(Orr et al., 1985).  Throughout the first 6 hours of
incubation, enzyme activity appears linear with respect to
time for both enzyme systems with kinetics after the sixth
hour of incubation difficult to determine.  Saturation of
the acetyl transferases observed in the presence of
excessive amounts of 2-AFA.
Saturation of the nitroreductase enzyme system found
within TA98 was determined by increasing the amount of 2-NFA
incubated with TA98 by a factor of 10.  The TA98 was only
able to convert approximately 23% (8.82 umoles) of the 2-NFA
to 2-AFA and 2% (0.68 umoles) to 2-NAAFA.  More 2-AFA and
2-NAAFA would have been produced in the excess of 2-AFA and
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2-NFA available for conversion if the nitroreductases and
acetyl tranferases responsible for their production had not
become saturated.
TA98 ND produced minimal quantities of 2-AFA and 2-NAAFA
through the first six hours of incubation (less than 10% of
the 2-NFA present had been converted).  However, by 24 hours
approximately 95% of the parent compound had been converted
to 2-AFA (80%) and 2-NAAFA (15%).  Determination of the
metabolic kinetics of the reactions requires additional
incubation times between 6 and 24 hours.  Saturation of the
acetyl transferase is suggested in the presence of excessive
amounts of 2-AFA (Figure 24, Table 6).  At some point
between 6 and 24 hours, either another nitroreductase is
induced in the bacteria, or the culture has become
sufficiently anaerobic that a previously silent oxygen-
sensitive reductase becomes active.
The metabolism of 2-NFA by TA98/1,8-DNP6 produced
minimal amounts of 2-AFA (13% of the original material) and
no 2-NAAFA within the first 6 hours of incubation (Figure
25, Table 7).  After 24 hours of incubation, approximately
92% of the 2-NFA had been converted to 2-AFA.  Once again,
the presence of another nitroreductase or silent
nitroreductase should be considered.  The lack of 2-NAAFA
produced in these incubations confirms the absence of acetyl
tranferase enzymes systems in  TA98/1,8-DNP6 (Orr et al.,
1985).
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2-AFA was identified as the principle metabolite of
2-NFA by HPLC, MS, and proton NMR analysis.  Relative
retention times and coelution with unlabeled 2-AFA suggested
the identity of the compound in the early stages of
analysis.  Comparison of the U.V. spectrum of the metabolite
with that of the standard also was consistent with the
structural assignment(Figure 18).  Mass spectrum of the
metabolite indicated a molecular ion expected for 2-AFA
(molecular weight 217).  Identification of fragmentation
products M-NH2 (M/z 200) and M-CNH (M/z 189) was also
possible.  A NMR spectrum obtained on the fraction showed
two singlets (H-1 and H-3) and one triplet (H-5) coupled to
two doublets (H-4 and H-6), all indicative of a naphthalene
ring structure (Figure 19).  The remainder of the protons
appeared as multiplets with comparable coupling constants as
would be expected for H-7, H-8, H-9 and H-10.
2-NAAFA was identified as the minor metabolic product by
HPLC and MS analysis.  When compared to the unlabeled
standard of 2-NAAFA, the fraction in question coeluted with
the standard and had a similar U.V. spectrum (Figure 20).
The MS showed a molecular ion with the weight expected for
2-NAAFA (M/z 259).  Fragmentation products of M-C2H2O (M/z
217) and M-NC2H4O (M/z 200) were also observed (Figure 27).
Unfortunately, TA98 and TA98 ND did not produce enough of
the metabolite to confirm the structural assignment of the
metabolite by proton NMR analysis.
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C.  Relevance to Mutagenicity
Most nitro-PAH are regarded as direct acting mutagens in
the Ames assay since they do not require exogenous
activation with S9 fractions (Rosenkranz et al., 1980;
Rosenkranz and Mermelstein, 1980).  It is thought that
nitro-PAH are biologically activated by the nitroreductase
and acetylase enzymes present in Salmonella tvphimurium
strain TA98 and its variants TA98 ND and TA98/1,8-DNP6.  The
nitroreductases present convert the nitro-PAHs to amino-PAHs
forming the arylhydroxylamine as an intermediate.  This
intermediate can be non-enzymatically converted to a highly
electrophilic arylnitrenium ion which can bind directly to
DNA (Rosenkranz et al., 1982; Rosenkranz and Mermelstein,
1983; Dietrich, 1987).
1-NP has been shown to be moderately mutagenic in strain
TA98 with a decrease in mutagenicity observed in the
nitroreductase deficient strain TA98 ND (Wang et al., 1975).
It is thought that the metabolic intermediate
1-nitrosopyrene is the probable mutagenic intermediate which
is further reduced to N-hydroxy-l-aminopyrene which can then
form a highly reactive electrophile (Howard et al., 1983a.,
Heflich et al., 1985).
The hypothesized route of mutagenicity of nitro-PAH is
further supported by 3-NFA's behavior in the Ames assay.
The parent compound is highly mutagenic in strain TA98 while
it is less mutagenic in strain TA98 ND ("classical"
nitroreductase deficient) and TA98/1,8-DNP6 (acetyl
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transferase deficient) (Griebokk et al., 1985; Ball et al.,
1985b; Ball et al., 1986; Ball, unpublished data).  The
final proposed metabolic products of 3-NFA, 3-AFA and
3-NAAFA, are also significantly less mutagenic than the
parent compound (Ball et al., 1985; Ball et al., 1986).
This implies that the metabolism of 3-NFA to 3-AFA via
"classical" nitroreductase and acetyl tranferase pathways is
an important step in the mutagenic activation of the
compound and further metabolism may only detoxify the
compound.
This study confirms that 3-NFA is quickly and
efficiently metabolized to 3-AFA by Salmonella typhimurium
strain TA98.  TA98 thus has the ability to produce
arylhydroxylamine intermediates thought responsible for
mutagenicity.  The compound is also metabolized to 3-AFA by
TA98 ND but at a slower rate, and/or by a different
nitroreductive enzyme system.  This alternative pathway may
not produce the same electrophilic intermediates necessary
for high levels of mutagenicity.
TA98/1,8-DNP6 is also able to produce 3-AFA from 3-NFA
yet still has a lower degree of mutagenicity.  This suggests
that even though the "classical" nitroreductive compounds
thought responsible for elevated levels of mutagenicity are
present, an additional step of transacetylation or an
alternative metabolic pathway may be required for
mutagenicity.  Since TA98/1,8-DNP6 is deficient in acetyl
transferase and possibly other as yet unidentified metabolic
54
.^
pathways, the electrophilic intermediates needed for
mutagenicity may not be present.
Recently, other studies in this laboratory have shown
that 2-NFA can be considered a slight to moderate mutagenic
compound proving to be 5 to 15 fold less mutagenic than
3-NFA with the metabolic products 2-AFA and 2-NAAFA
producing very little mutagenicity (Ball, unpublished data).
The mutagenicity of 2-NFA observed is attributed to the
"classical" nitroreductive capacity of the Salmonella
typhimurium strains.  TA98 had a higher mutagenic response
than the TA98 ND strain deficient suggesting once again that
"classical" nitroreduction is an important pathway for
mutagenicity.  TA98/1,8-DNP6 also showed a lower level of
mutagenicity when compared to TA98.  This suggests once
again that acetyl transferases or some other metabolic
pathway is important in the mutagenic response of these
compounds.
The lower mutagenicity of 2-NFA compared to 3-NFA is
consistent with the slower rate of metabolism of 2-NFA in
all strains of Salmonella typhimurium.  The slower rate of
metabolism could be indicative of the strains' decreased
ability to metabolize this isomer of nitrofluoranthene.
Without metabolism, mutagenicity can not occur.
The positional isomerism of the nitro group on the
fluoranthene molecule may affect the metabolism of the
isomers.  The nitro group of 3-NFA is situated along the
long axis of the molecule (Figure 2), a factor Vance and
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Levin (1984) consider important for efficient nitroreductive
metabolism of the compound.  The nitro group of 2-NFA is
positioned off the long axis (Figure 1) this change in
geometry may be enough to decrease the rate of metabolism of
2-NFA by interferring with the access to the active site of
the nitroreductase thereby decreasing mutagenicity.
D.  Future Work
Definitive confirmation by NMR analysis of the 2-NAAFA
produced by TA98 and TA98 ND incubated with 2-NFA should be
considered.  Unfortunately, the Salmonella tvphimurium
strains produce small quatities of the metabolite as the
acetyl tranferase enzyme responsible appears to become
staurated in the presence of even small amounts of 2-AFA,
the precursor of 2-NAAFA.
Additional incubations of varying concentrations of
substrate and increased time of incubation should be
considered to determine the kinetics of the metabolism of
3-NFA and 2-NFA.
The mutagenicity of the metabolites produced directly
from the bacterial incubations should be evaluated by the
Ames assay to determine whether these compounds yield the
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Fig. 4 Proposed Mechanism for Metabolism of 2-NFA
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Fig. 5  Representative HPLC Chromatogram (254 nm)
of Extracted 3-NFA and Salmonella
typhimurium Incubations (Program I)
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Fig. 6 Representative HPLC Cliromatogram of Fraction I






Fig. 7 UV-VIS Spectrum of Fraction 1
Fraction 1 3-AFA Standard




Fig. 8 UV-ViS Spectrum of Fraction 2
Fraction 2 3-NFA Standard
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Fig. 9  Representative Radioactivity Profile of Extracted
14C-3NFA Incubations vs. Chromatogram












TABLE   1
RADIOACTIVE METABOLITES OF







a. % radioactivity present as fraction 1
b. n = 2
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RADIOACTIVE METABOLITES OF
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Table 4
PROTON NMR CHARACTERISTICS OF FRACTION 1 (3-AFA)
Chemical Shift^' Splitting J Proton
(ppm) Pattern (Hz)
8.15 doublet (8.0) H-1
8.05 doublet (6.8) H-6
7.95 doublet (7.4, 0.9) H-7 or H-10
7.80 doublet (8.3) H-4
7.78 doublet (7.5, 0.9) H-7 or H-10
7.58 triplet (6.9, 8.3) H-5
7.31 triplet (7.5, 7.5, 1.1) H-8 or H-9
7.22 triplet (7.5, 7.5, 1.0) H-8 or H-9
6.80 doublet (7.6) H-2
a.  Integral for resonance signals was 1 proton
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Fig. 16 Representative HPLC Chromatogram (254 nm)
of Extracted 2-NFA and Salmonella typhimurium







Fig. 17 Representative HPLC Chromatogram (254 nm)
of Extracted 2-NFA and Salmonella tvphimurium
TA98/1,8-DNP6 Incubation (Program II)
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Fig. 18 UV-VIS Spectrum of Fraction A
Fraction A 2-AFA Standard
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Fig. 20 UV-ViS Spectrum of Fraction C
Fraction C 2-NFA Standard
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Fig. 21   Representative Radioactivity Profile of Extracted
3H-2NFA and TA98/TA98 ND Incubations vs.





Fig. 22 Representative Radioactivity Profile of Extracted
3H-2NFA and TA98/1,8-DNP6 Incubations vs.






















TABLE   5
















%   2--NAAFA"
1.7 +   0.1
2.7 +   0.5
5.8 +   1.7
7.9 +   2.8
10.9 +   1.9
15.9 +   0.9
a. % radioactivity present as fraction A
b. n = 2
c. + standard deviation
d. ¥ radioactivity present as fraction B
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Fig. 24
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TABLE   6
RADIOACTIVE METABOLITES OF 3H-2NFA
INCUBATED WITH TA98 ND
Time   (hour) %   2-AFA^-**•<=• %   2-NAAFA<
0.5 1.4   +   0.7 0.6   +   0.1
1.0 2.1   +   1.0 1.0   +   0.4
2.0 2.9   +   1.6 1.2   +   0.5
3.0 3.1   +   1.5 1.9   +   0.7
6.0 2.7   +   1.1 3.4   +   1.2
24.0 80.1   +   2.8 14.7   +   1.6
a. % radioactivity present as fraction A
b. n = 2
c. + standard deviation



















TABLE   7
RADOACTIVE METABOLITES OF 3H-2NFA
INCUBATED WITH TA98/1,8-DNP6
Time   (hour) %   2-AFA*"'
0.5 2.3   +   0.5
1.0 2.7   +   1.0
2.0 3.9   +   0.9
3.0 5.7   +   1.1
6.0 13.3   +   1.4








a. % radioactivity present in fraction A
b. n = 2
c. + standard deviation




























Fig. 26 IWIass Spectrum of Fraction A
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TABLE 8
PROTON NMR CHARACTERISTICS OF FRACTION A (2-AFA)
Chemical Shifts^- Splitting J Proton
(ppm) Pattern (Hz)
7.93 multiplet (7.7, 1.4) H-7 or H-10
7.90 multiplet (7.4, 1.4) H-7 or H-10




7.58 doublet (6.5) H-4
7.50 triplet (6.8, 7.9) H-5
7.36 2 super-imposed
multiplets
(7.5, 1.7) H-8 & H-9
6.99 meta-coupled (1.6) H-3
Integral for resonance signal was 1 proton
87
VI.  REFERENCES
Ames, B.N., J. McCann, and E. Yamasaki (1975). "Methods for
Detection of Carcinogens and Mutagens with the
Salmonella/Mammalian Microsome Test", Mutation Research. 31,
pp. 347-364.
Andrews, P.J., M.A. Quilliam, B.E. McCarry, D.W. Bryant, and
D.R. McCalla (1986). "Identification of the DNA Adduct
Formed by the Metabolism of 1,8-Dinitropyrene in Salmonella
typhimurium". Carcinogenesis, 7, pp. 105-110.
Ball, L.M., M.J. Kohan, K. Williams, M.G. Nishioka, and J.
Lewtas (1987). "Metabolism and Activation Pathways of the
Environmental Mutagen 3-Nitrofluoranthene", in Polvnuclear
Aromatic Hydrocarbons: A Decade of Progress, W.M. Cooke and
A.J. Dennis (eds.), Batelle Columbus Press, Columbus, OH.
Ball, L.M., M.G. Nishioka, and J. Lewtas (1986a.). "Hepatic
Metabolism of the Environmental Mutagen
2-Nitrofluoranthene", in Proceedings of the Eleventh
International Symposium on Polycyclic Aromatic Hydrocarbons.
W.M. Cooke and W.E. May (eds.), Lewis Publisher.
Ball, L.M., K. Williams, M.J. Kohan, and J. Lewtas (1986b.).
"S9-Dependent Activation of 1-Nitropyrene and
3-Nitrofluoranthene in Bacterial Mutagenicity Assays", in
Biological Reactive Intermediates III,   J.J. Kocsis, D.J.
Jollow, CM. Witmer, J.O. Nelson, and R. Snyder (eds.).
Plenum Publishing, NY, pp. 781-788.
Ball, L.M., and L.C. King (1985). "Metabolism, Mutagenicity,
and Activation of 1-Nitropyrene jji Vivo and in Vitro",
Environment International. 11, pp. 335-362.
Ball, L.M., M.G. Nishioka, and J. Lewtas (1985). "Hepatic
Metabolism of the Environmental Mutagen
3-Nitrofluoranthene", Pharmacologist. 27, p. 263.
Ball, L.M., M.J. Kohan, L.D. Claxton, and J. Lewtas
(1984a.). "Mutagenicity of Derivatives and Metabolites of
1-Nitropyrene:  Activation by Rat Liver S9 and Bacterial
Enzymes", Mutation Research. 138, pp. 113-125.
Ball, L.M., M.J. Kohan, L.D. Claxton, and J. Lewtas
(1984b.). "Metabolism of l-Nitro[^"^Clpyrene in Vivo in the
Rat and Mutagenicity of Urinary Metabolites",
Carcinogenesis. 5, pp. 1557-1564.
Berry, D.L., G.M. Schoofs, and W.A. Vance (1985).
"Mutagenicity of Nitrofluoranthenes and 1-Nitropyrene in
Chinese Hamster V79 Cells", Carcinogenesis. 6(10),
pp. 1403-1407.
88
Blake, A. and A.R. Peacocke (1968). "The Interaction of
Aminoacridines with Nucleic Acids", Biopolymers. 6,
pp. 1225-1253.
Bond, J.A. and J.L. Mauderly (1984). "Metabolism and
Macromolecular Covalent Binding of ^^C-1-Nitropyrene in
Isolated Perfused and Ventilated Rat Lungs", Cancer
Research, 44, pp. 3924-3929.
Bond, J.A., M.A. Medinsky, and J.S. Dutcher (1984).
"Metabolism of l-[-^^C]-Nitropyrene in Isolated Perfused Rat
Livers", Toxicology and Applied Physiology. 75, pp. 531-538.
Brooks, A.L., R.K. Wolff, R.E. Royer, C.R. Clark, A.
Samchez, and R.O. McCullan (1980). "Biological Availability
of Mutagenic Chemicals Associated with Diesel Exhaust
Particles", in Health Effects of Diesel Engine Emissions.
W.E. Pepelko, R.M. Danner, and N.A. Clark (eds.), USEPA,
Cincinatti, OH, EPA-600/9-80-057A, 1, pp.345-558.
Brorstrom-Lunden, E. and A. Lindskog (1985).
"Characterization of Organic Compounds on Airborne
Particulates", Environment Interbational. 11, pp. 183-188.
Dietrich, A.M. (1987). Mass Spectrometric Characterization
of DNA Adducts Formed from 3-Nitrofluoranthene, PhD. Thesis,
University of North Carolina.
DiPaolo, J.A., A.J. DeMarinis, F.L. Chow, R.C. Garner, C.N.
Martin, and J. Doniger (1983). "Nitration of Carcinogenic
and Non-carcinogenic Polycyclic Aromatic Hydrocarbons
Results in Products Able to Induce Transformation of Syrian
Hamster Cells", Carcinogenesis. 4, pp. 358-359.
Djuric, Z., E.K. Fifer, P.C. Howard, and F.A. Beland (1986).
"Oxidative Microsomal Metabolism of 1-Nitropyrene and DNA
binding of Oxidized Metabolites Following Nitroreduction",
Carcinogenesis, 7, pp. 1073-1079.
Edwards, M.J., S. Batmanghelich, S, Edwards, J.M. Parry, and
K. Smith (1986). "The Induction of DNA Adducts in Mammalian
Cells Exposed to 1-Nitropyrene and Its Nitro-reduced
Derivatives", Mutagenesis. 1, pp. 347-3 52.
El-Bayoumy, K. and S.S. Hecht (1983). "Identification and
Mutagenicity of Metabolites of 1-Nitopyrene Formed by Rat
Liver", Cancer Research, 43, pp. 3132-3137.
Farber, E. (1981). "Chemical Carcinogenesis", New England
Journal of Medicine, 305, pp. 1379-1389.
89
Gallagher, J.E., I.G.C. Robertson, M.A. Dietrich, L.M. Ball,
and J. Lewtas (1987). "^^p.postlabeling Analysis of Two
Nitrated Polycyclic Aromatic Hydrocarbons in Rabbit Tracheal
Epithelial Cells", in Proceedings of the Third Inernational
Conference on Carcinogenic and Mutagenic N-Substituted Aryl
Compounds. Charles King (ed.),   Elsevier Publishing.
Gibson, T.L. (1982). "Nitroderivatives of Polyaromatic
Hydrocarbons in Airborne and Source Particulate Matter",
Atmospheric Environment. 16, pp. 2037-2040.
Goldring, J.M.. (1986). Personal Communication, in Mass
Spectrometric Characterization of DNA Adducts Formed from 3-
Nitrofluoranthene. a dissertation by A.M. Dietrich (1987).
Greibrokk, T., G. Lofroth, L. Nilssen, R. Tofgard, J.
Carlstedt-Duke, and J.A. Gustafsson (1985). "Nitroarenes:
Mutagenicity in the Ames Salmonella/Microsome Assay for the
TCDD-receptor Protein", in Toxicity of Nitroaromatic
Compounds. D.E. Rickert (ed.), Hemisphere, Washington, D.C.,
pp. 167-181.
Heflich, R.H., P.C. Howard, and F.A. Beland (1985).
"1-Nitrosopyrene:  An Intermediate in the Metabolic
Activation of 1-Nitropyrene to a Mutagen in Salmonella
typhimurium TA 1538", Mutation Research, 149, pp. 25-32.
Heflich, R.H., N.H. Fullerton, and F.A. Beland (1986). "An
Examination of the Weak Mutagenic Response of 1-Nitropyrene
in Chinese Hamster Ovary Cells", Mutation Research. 161,
pp. 99-108.
Hemminki, K. (1983). "Nucleic Acid Adducts of Chemical
Carcinogens and Mutagens", Archives of Toxicology. 52,
pp. 249-285.
Henderson, T.R., J.D. Sun, R.E. Rouer, C.R. Clark, A.P. Li,
T.M. Hawey, D.H. Hunt, J.E. Fulford, A.M. Lovette, and J.
Lewtas (1983). "Triple-Quadropole Mass Spectrometry Studies
on Nitro-aromatic Emissions from Different Diesel Engines",
Environmental Science and Technology. 17, pp. 445-449.
Hirose, M., M.S. Lee, C.Y. Wang, and CM. King (1984)
"Induction of Rat Mammary Gland Tumors by 1-Nitropyrene, a
Recently Recognized Environmental Mutagen", Cancer Research.
44, pp. 1158-1162.
Howard, P.C, G.D. Nateescu, and M.C Console (1988). "Liver
Microsomal Metabolism of Environmental Carcinogens
3-Nitrofluoranthene:  I. Phenolic Metabolites",
Carcinogenesis. 9, pp. 911-917.
90
Howard, P.C.., T.J. Flammang, and F.A. Beland (1985).
"Comparison of the in Vitro and in Vivo Hepatic Metabolism
of the Carcinogen 1-Nitropyrene", Carcinogenesis. 6,
pp. 243-249.
Howard, P.C, F.A. Beland, and C.E. Cerniglia (1983a.).
"Reduction of the Carcinogen 1-Nitropyrene by Rat Intestinal
bacteria", Carcinogenesis. 4, pp. 985-990.
Howard, P.C, R.H. Heflich, F.E. Evans, and F.A. Beland
(1983b.). "Formation of DNA Adducts in Vitro and in
Salmonella typhimurium upon Metabolic Reduction of the
Environmental Mutagen 1-Nitropyrene", Cancer Research. 43,
pp. 2052-2059.
Howard, P.C, and F. Beland (1982). "Xanthine Oxidase
Catalyzed Binding of 1-Nitropyrene to DNA", Biochemical and
Biophysical Research Communications, 104, pp. 727-732.
Jackson, M.A., L.C Ball, S. Ghayourmanesh, A.M. Jeffrey,
and J. Lewtas (1985). "Nitropyrene:  DNA Binding and Adduct
Formation in Respiratory Tissues", Environmental Health
Perspectives. 62, pp. 203-207,
Kamens, R.M., J.M. Perry, D.A. Bell, D.L. Newton, and B.
Brand (1985). "Factors Which Influence Polyaromatic
Hydrocarbon Decomposition on Wood Smoke Particle",
Environmental International, 11, pp. 131-136.
Karpinsky, G.E., E.G. McCoy, and H.S. Rosenkranz (1982).
"The Chemical Activation of Non-mutagenic Nitrated
Polycyclic Aromatic Hydrocarbons to Mutagens", Mutation
Research. 92, pp. 29-37.
King L.C, M. Jackson, L.M. Ball, and J. Lewtas (1987).
"Metabolism and DNA Binding of l-Nitro[^^C]-pyrene by
Isolated Rabbit Tracheal Epithelial Cells", Carcinogenesis,
8, pp. 675-682.
King, L.C, M.J. Kohan, L.M. Ball and J. Lewtas (1984).
"Mutagenicity of Lung Metabolites from Lung S9", Cancer
Letters, 22, pp. 255-262.
King, L.C, K. Loud, S.B. Tejada, and M.J. Kohan (1983a.).
"Evaluation of the Release of Mutagens and 1-Nitropyrene
from Diesel Particles in the Presence of Lung Macrophage
Cells in Culture", Environmental Mutagen. 5, pp. 577-578.
King, L.C. M. Jackson, L.M. Ball, and J. Lewtas (1983b.).
"Binding of l-Nitro[ ^"^C]-pyrene to DNA and Protein in
Cultured Lung Macrophages and Repsiratory Tissue", Cancer
Letters. 19, pp. 241-246.
91
King, L.C., M.J. Kohan, A.C. Austin, L.D. Claxton, and J.H.
Huisingh (1981). "Evaluation of the Release of Mutagens from
Diesel Particles in the Presence of Physiological Fluids",
Environmental Mutagen. 3, pp. 109-121.
Kirshner, S.L. (1988). Identification of the Metabolites of
3-Nitrofluoranthene f3-NF) and Assessment of Their
Mutagenicity. M.S. Thesis, University of North Carolina.
Kloetzel, M.C., W. King, and J.M. Menkes (1955).
"Fluoranthene Derivatives:  III. 2-Nitrofluoranthene and
2-Aminofluoranthene", Journal of the American Chemical
Society. 78, pp. 1165-1169.
Klopman, G. and H.S. Rosenkranz (1984).  "Structural
Rec[uirements for the Mutagenicity of Environmental
Nitroarenes", Mutation Research. 126, pp. 227-238.
Later, D.W., M.J. Lee, R.A. Pelroy, and B.W. Wilson
(1982). "Identification and Mutagenicity of Nitrogen
Containing Polycyclic Aromatic Compounds in Synthetic
Fuels", in Physical and Biological Chemistry, M. Cooke, A.J.
Dennis, and G.L. Tischer (eds.), Batelle Columbus Press,
Columbus, Ohio, pp. 427-438.
Lehninger, A.L. (1975). Biochemistry. Worth Publishers, N.Y.
Lewtas, J. (1983). "Evaluation of the Mutagenicity and
Carcinogenicity of Motor Vehicle Emissions in Short-term
Bioassays", Environmental Health Perspectives, 47,
pp. 141-152.
Lofroth, G., E. Hefner, I. Alfheim, and M. Moller (1980).
"Mutagenic Activity of Photocopies", Science. 209,
pp. 1037-1039.
Lofroth, G. (1980). "Comparison of the Mutagenic Activity in
Carbon Particulate Matter and in Diesel and Gasoline Engine
Exhaust", in Short-term Bioassays in the Analysis of Complex
Environmental Mixtures II, M.D. Waters, S.S. Sandhu, J.
Lewtas, J. Huisingh, and S. Nesnow (eds.). Plenum Press, NY.
Lutz, W.K. (1979). "In Vivo Covalent Binding of Organic
Chemicals to DNA as a Quantitative Indicator in the Process
of Chemical Carcinogenesis", Mutation Research. 65,
pp. 289-356.
Maron, D.M. and B.N. Ames (198 3). "Revised Methods for the
Salmonella Mutagenicity Test", Mutation Research. 113,
pp. 173-215.
92
Martin, C.N., F.A. Beland, R.W. Roth, and F.F. Kadlubar
(1982). "Covalent Binding of Benzidine and N-Acetylbenzidine
to DNA at the C-8 Atom of Deoxyguanosine in Vivo and in
Vitro". Cancer Research, 42, pp. 2678-2696.
McCoy, E.G., G.D. McCoy, and H.S. Rosenkranz (1983). "The
Basis of the Intensity of Salmonella tvphimurium Strain
TA98/1,8-DNP6 to the Mutagenic Action of Nitroarenes",
Mutation Research, 121, pp. 17-23.
McCoy, B.C., H.S. Rosenkranz, and R. Mermelstein (1981).
"Evidence for the Existence of a Family of Bacterial
Nitroreductases Capable of Activating Nitrated Polycyclics
to Mutagens", Environmental Mutagen. 3, pp. 421-427.
Mermelstein, R., H.S. Rosenkranz, and E.C. McCoy (1981).
"The Microbial Mutagenicity of Nitroarenes", in AUI/BLN
Symposium on Genotoxic Effects of Airborne Agents,
pp. 369-410.
Messier, F., C. Lu, P. Andrews, B.E. McCarry, M.A. Quilliam,
and D.R. McCalla (1981). "Metabolism of 1-Nitropyrene and
Formation of DNA Adducts in Salmonella typhimurium",
Carcinogenesis, 2, pp. 1007-1011.
Miller, J.A. and E.C. Miller (1977). "Ultimate Chemical
Carcinogen as Reactive Mutagenic Electrophiles", in Origins
of Human Carcinogens, H.H. Hiatt, J.D. Watson and J.A.
Winsted (eds.), Cold Springs Harbor Laboratory,
pp. 605-625.
Nielsen, T. (1984) . "Reactivity of Polycyclic Aromatic
Hydrocarbons Toward Nitrating Species", Environmental
Science and Technology, 18, pp. 157-163.
Nielsen, T., B. Sietz, and T. Ramdahl (1984). "Occurrence of
Nitro-PAH in the Atmosphere of Rural Areas", Atmospheric
Environment. 18, pp. 2159-2165.
Nielsen, T., T., Ramdahl, and A. Bjorseth (1983). "The Fate
of Airborne Polycyclic Organic Matter", Environmental Health
Perspective. 47, 103-114.
Nishioka, M.G., B.A. Peterson, and J. Lewtas (1982).
"Comparison of Nitroaromatic Content and Direct-Acting
Mutagenicity of Diesel Emissions", in Polynuclear Aromatic
Hydrocarbons; Physical and Biological Chemistry, W.M. Cooke,
A.J. Dennis, and G. Fisher (eds.), Battelle Columbus Press,
Columbus, OH, pp. 603-613.
93
Oghaki, H., N. Matsukara, K. Morino, T. Kawachi, T.
Sugimura, K. Morita, H. Tokiwa, and T. Hirota (198 2).
"Carcinogenicity in Rats of Mutagenic Compounds
1-Nitropyrene and 3-Nitrofluoranthene", Cancer Letters. 15,
pp. 1-7.
Orr, J.C., D.W. Bryant, D.R. McCalla, and M.A. Quilliam
(1985). "Dinitropyrene-resistant Salmonella tvphimurium are
Deficient in an Acetyl-CoA Transferase", Chemical-
Biological Interactions, 54, pp. 281-288.
Patton, J.D., V.M. Mahler, and J.J. McCormick (1986).
"Cytotoxicity and Mutagenic Effects of 1-Nitropyrene and
1-Nitrosopyrene in Diploid Human Fibroblasts",
Carcinogenesis. 7, pp. 89-93.
Peterson, F.T., R.P. Mason, J. Hovspian, and J.L. Holzman
(1979). "Oxygen Sensitive and Insensitive Nitroreduction by
Escherichia coli and Rat Hepatic Microsomes", Journal of
Biological Chemistry. 254, pp. 4009-4014.
Pitts, J.N., Jr., J.A. Sweetman, B. Zielinska, A.M. Winer,
and R. Akinson (1985). "Determination of 2-Nitrofluoranthene
and 2-Nitropyrene in Ambient Particulate organic Matter:
Evidence for Atmospheric Reactions", Atmospheric
Environment. 19, pp. 1601-1608.
Pitts, J.N., Jr., (1983). "Formation and Fate of Gaseous and
Particulate Mutagens and Carcinogens in Real and Simulated
Atmospheres", Environmental Health Perspectives. 47,
pp. 115-140.
Rosenkranz, E.J., E.C. McCoy, R. Mermelstein, and H.S.
Rosenkranz (1982). "Evidence for Distinct Nitroreductases in
Salmonella typhimurium;  Roles in Mutagenesis",
Carcinogenesis, 3, pp. 121-123.
Rosenkranz, H.S. and R. Mermelstein (1983). "Mutagenicity
and Genotoxicity of Nitroarenes:  All Nitro-containing
Chemicals Were Not Created Equal", Mutation Research, 114,
pp. 217-267.
Rosenkranz, H.S., E.C. McCoy, D.R. Sanders, M. Butler, D.K.
Kiriazides, and R. Mermelstein (1980). "Nitropyrene:
Isolation, Identification, and Reduction of Mutagenic
Impurities in Carbon Black and Toners", Science, 209,
pp. 1039-1043.
Schroder, E.H., H. Munster, and H. Budzikiewicz (1986).
"Ionization by Fast Atom Bombardment:  A Chemical Ionization
(matrix) Process in the Gas Phase", Organic Mass
Spectrometry. 21, pp. 707-715.
94
m
Schuetzle, D. and T.E. Jensen (1985). "Analysis of Nitrated
Polycyclic Aromatic Hydrocarbons (nitro-PAH) by Mass
Spectrometry", in Nitrated Polycyclic Aromatic Hydrocarbons.
CM. White (ed.), Heidelberg:  Dr. Alfred Huethig, pp. 121-
127.
Schuetzle, D. (1983). "Sampling of Vehicle Emissions for
Chemical Analysis and Biological Testing", Environmental
Health Perspective. 47, pp. 65-80.
Schuetzle, D., T.L. Riley, T.J. Prater, T.M. Harvey, and
D.F. Hunt (1982). "Analysis of Polycyclic Aromatic
Hydrocarbons in Diesel Particulates", Analytical Chemistry.
54, pp. 265-271.
Silverstein. R.M., G.C. Clayton, and T.C. Merrill (1981).
"Mass Spectrometry", in Spectrometric Identifiction of
Organic Compounds. John Wiley and Sons, NY, pp. 3 - 16.
Singer, B. and D. Grunberger (1983). Molecular Biology of
Mutagens and Carcinogens. Plenum Press, NY.
Stanton, C.A., F.L. Chow, D.H. Phillips, P.L. Grover, R.C.
Garner, and C.N. Martin (1985). "Evidence for N-(deoxy-
guanosin-8-yl)-1-aminopyrene as a Major Adduct in Female
Rats Treated with 1-Nitropyrene", Carcinogenesis, 6, pp.
535-538.
van Houte, L.P.A., J.T. Bokman, J.T. Lutgering, J.G. Westra,
J. Retel, R. van Grondelle, and J. Blok (1987). "An Optical
Study of the Conformation of the Aminofluorene-DNA Complex",
Carcinogenesis. 8, pp. 759-766.
Vance, W.A. and D.E. Levin (1984). "Structural features of
Nitroaromatics that Determine Mutagenic Activity in
Salmonella typhimurium". Environmental Mutagenesis. 6,
pp. 797-811.
Wang, C.T., C.W. Chui, B. Kaiman, and G.T. Bryant (1975).
"Identification of 2-methyl-4-(5-amino-2-furyl)thiazole as
the Reduced Metabolite of 2-methyl-4-(5-nitro-2-
furyl)thiazole", Biochemical Pharmacology, 24,
pp. 291-293.
Watson, J.T. (1985). Introduction to Mass Spectrometry.
Raven Press, NY.
Westra, J.G. (1981). "A Rapid and Simple Synthesis of
Reactive Metabolites of Carcinogenic Aromatic Amines in High
Yield", Carcinogenesis. 2, pp. 355-357.
95
wise, S.A., S.N. Chesler, L.R. Hilpert, W.E. May, R.E.
Rebbert, C.R. Vogt, M.G. Nishioka, A. Austin, and J. Lewtas
(1985). "Quantification of Polycyclic Aromatic Hydrocarbons
and Nitro-Substituted Polycyclic Aromatic Hydrocarbons and
Mutagenicity Testing for the Characterization of Ambient
Particulate Matter", Environment International. 11,
pp. 147-160.
Wislocki, P.G., E.S. Bagan, A.Y.H. Lu, K.L. Dooley, P.P. Fu,
H. Han-Hsu, F.A. Beland, and F.K. Kadlubar (1986).
"Tumorigenicity of Nitrated Derivatives of Pyrene,
Benz(a)anthracene, Chrysene, and Benz(a)pyrene in the
Newborn Mouse Assay", Carcinogenesis. 7, pp. 1317-1322.
Wong, D., C.E. Mitchell, R.K. Wolff, J.L. Mauderly, and A.M.
Jeffrey (1986). "Identification of DNA Damage as a result of
Exposure of Rats to Diesel Engine Exhaust", Carcinogenesis^
7, pp. 1595-1597.
Zielinska, B., W.P. Harger, J. Arey, A.M. Winer, R.A. Haas,
and C.V. Hanson (1987). "The Mutagenicity of
2-Nitrofluoranthene and Its in Vitro Hepatic Metabolites",
Mutation Research, 190, pp. 259-266.
Zielinska, B., J. Arey, R. Atkinson, T. Ramdahl, A.M. Winer,
and J.N. Pitts, Jr. (1986). "Reaction of Dinitrogen
Pentoxide with Fluoranthene", Journal of the American
Chemical Society. 108, pp. 4126-4132.
96
